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SUMMARY 
Animal development from a single cell zygote to a multicellular organism 
requires the spatio-temporal regulation of several signalling pathways and regulatory 
molecules. These coordinate a number of cellular functions including cell 
proliferation, differentiation and tissue morphogenesis. Model organisms have 
become irreplaceable tools in fundamental biological research helping scientists to 
amass a vast amount of knowledge in defining the basic concepts that underlie 
cellular functions. This thesis describes the work that utilises the fruit fly, Drosophila 
melanogaster to study some aspects of myogenesis. 
Drosophila body wall muscles are multinucleate fibres formed in the embryo 
by the fusion of founder cells (FC) and fusion competent myoblasts (FCM). The FCs 
carry all the information required for muscle formation and the FCMs contribute to 
muscle size by fusing with the FC to give rise to a stereotypic pattern of muscles in 
every hemisegment of the fly embryo. FCs fuse with FCMs to first form a 
bi/trinucleate precursor, which then fuses with more FCMs in successive rounds of 
fusion to form the mature muscle. Concurrently, muscles undergo terminal 
differentiation by expressing contractile proteins, attaching to specific epidermal sites 
and making contacts with motor neurons. Both myoblast fusion and terminal muscle 
differentiation are critical for muscle development and function. The work described 
in this thesis, uses the Drosophila embryo to gain some insight into these processes. 
The results are presented in three chapters, followed by a common discussion. 
Chapter 3 deals with the analysis of the transmembrane receptor and myoblast 
attractant, Dumbfounded (Duf), that is known to be critical for the initiation of 
myoblast fusion.  I address how founder specific extracellular signals, via Duf, are 
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transduced intracellularly to downstream effectors, Rolling pebbles (Rols) and Loner 
that have been implicated in cytoskeletal reorganisation after precursor formation. 
Studies were carried out using a Duf structure/function analysis approach. These 
results suggest that putative Duf signaling domains act additively to affect fusion. 
Chapter 4 shows that Rols and Loner previously thought to function in a Duf 
dependent manner, after the formation of the precursor, also have a role in the first 
round of fusion that seems to be independent of Duf. The analysis of other mutants 
suggests that many of them might act simultaneously to ensure efficient fusion. 
Chapter 5 deals with the terminal differentiation of muscles. I carried out a 
mutagenesis screen that led to the identification of a mutation in a novel gene, muscle 
wasted (mute). Severe muscle degeneration is observed with a reduction in levels of a 
key muscle differentiation factor, Drosophila myocyte enhancer factor 2 (Dmef2) and 
some of its target genes. Mute appears to be a component of the histone locus body, a 
nuclear organelle comprising histone mRNA processing factors. This work also 
shows that mute is required for histone pre-mRNA processing. Defects in the 
presentation of heterochromatin protein-1 imply changes in the organisation of 
heterochromatin.   
 Chapter 6 summarises these studies performed on two diverse aspects of 
myogenesis, myoblast fusion and terminal muscle differentiation. 
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Multicellular organisms arise by a process of progressive change that we call 
development. Animal development is a spectacular process which represents the 
spatio-temporal control of gene expression that results in cell growth, differentiation 
and morphogenesis, that gives rise to tissues, organs and anatomy. Development 
accomplishes two major objectives: it generates cellular diversity and order within 
each generation, and it ensures the continuity of life from one generation to the next. 
One of the fundamental questions in biology has been: How does a complex 
multicellular organism develop from a single fertilised zygote? We now know, all the 
information necessary to specify every cell type is present in the identical DNA 
contained in each cell. But the question is: what is the program that directs the use of 
this DNA information, and how does it work? 
A model organism is a species that is extensively utilised and studied to 
understand particular biological phenomena, with the expectation that discoveries 
made will provide insight into the workings of other organisms, in particular humans. 
This strategy is made possible by the common descent of all living organisms, and the 
conservation of metabolic and developmental pathways in addition to genetic 
material, over the course of evolution. Each model organism has its advantages and 
disadvantages and the best combination determines which would be the most useful to 
uncover certain aspects of development.  
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1.1 Drosophila melanogaster as a model organism: 
Two of the most widely used invertebrate model organisms have been the fruit 
fly, Drosophila melanogaster and the nematode, Caenorhabditis elegans. For the past 
century, researchers have utilised the fruit fly to elucidate the mechanisms that govern 
various developmental processes like patterning, specification and differentiation of 
cell types, growth and morphogenesis of tissues like the epithelium, mesoderm and 
nervous system, to name a few. While it is true that there are differences between flies 
and vertebrates, it is clear that the similarities are far more overwhelming. The fruit 
fly has contributed to many basic biological discoveries and given us several insights 
into conserved developmental mechanisms.  
Some of the main advantages of Drosophila as a model organism are: 
• Short lifecycle (~10 days at 25°C), large numbers of progeny, low cost and 
ease of maintenance 
• Amenability to genetic manipulation. It is possible to make mutations in the 
whole fly or as mosaics where only a certain population of cells in a tissue 
carries the mutation. In addition, the availability of balancer chromosomes 
ensures that a mutant chromosome can be maintained. Also, tissue specific 
promoters can be used for the targeted mis-expression of molecules, using the 
UAS-GAL4 system. 
• Effects of mutations can be easily visualised. 
• The fly genome has been completely sequenced and is well annotated. 
• Life cycle and developmental stages have been well documented thus making 
it easy to study due to the presence of useful guides. 
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• Well established databases for gene expression patterns, gene interactions and 
fly stocks/other associated reagents. 
1.1.1 Drosophila life cycle: 
Drosophila has a short lifecycle of 10 days at 25ºC as depicted in Figure 1.1. 
Following fertilisation, the embryo develops from a single cell, characterised by a 
series of specific developmental events. At the end of embryogenesis (~22h after egg 
laying, AEL), hatching occurs giving rise to the larva that goes through three larval 
instars as it develops over ~4 days. The larva then pupates for ~5 days during which 








Figure 1.1: Drosophila life cycle 
Adapted from FlyMove (http://flymove.uni-muenster.de/). The life cycle of the fly 
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1.1.2 Drosophila embryogenesis: 
Embryonic development involves significant changes to the fertilised egg. 
Although this is a continuous process, embryologists have frequently emphasised 
landmark events which have permitted the subdivision of embryonic development 
into a series of different stages. Each stage provides a reference point for describing 
embryonic development. From 0 to ~22 hours AEL the embryo progresses from 
developmental stage 1 to stage 17 finally hatching into the first instar larva (Figure 
1.2) (Campos-Ortega and Hartenstein, 1985). 
After fertilisation the zygotic nuclei divide 13 times before cellularisation to 
form the blastoderm, a simple monolayer of cells. Gastrulation follows during which 
morphogenetic movements lead to the gradual invagination of a midventral cell band 
that eventually gives rise to a tubular structure inside the embryo. Changes in cell 
shape, size, and movement of cells relative to each other lead to the formation of a 
three dimensional embryo with a basic body pattern.  In Drosophila terminology the 
germ band consists of the main trunk of the future embryo, the part that will become 
segmented. Segments throughout the germ band have similar organisation and 
comprise epidermal, neural and mesodermal components. The germ band initially 
elongates, bringing about drastic changes to the ectodermal and mesodermal 
primordia. Mitotic divisions lead to the growth of various internal organs particularly 
of the gut and mesoderm primordium. Germ band shortening follows, permitting the 
establishment of normal anatomical relationships of the larva. Simultaneously dorsal 
closure occurs by stretching of the dorsal epidermal primordium on either side of the 
embryo to fuse at the dorsal midline. Complex morphogenetic movements lead to 
head involution. These events signify the completion of morphogenesis and the end of 
embryogenesis. At this stage the segmented body of the embryo can be divided into 
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the anterior acron followed by 3 thoracic segments (T1-T3), 8 abdominal segments 
(A1-A8) ending posteriorly in the telson. The work presented in this thesis focuses 
mainly on muscles of the abdominal segments between stages 14-16 that corresponds 
to the peak of muscle formation and differentiation. 
Chapter 1    Introduction 
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Figure 1.2 Embryonic stages of Drosophila development. Adapted from 
(Hartenstein, 1993) 
These depict germ band (red), ventral nerve cord (yellow) and gut (green). Changes in 
gut morphology assist in identifying embryos between stages 12-17. 
Schematic Stage Time (hours) Developmental Features 
 
1-4 0:00 - 2:10 h 
Cleavage, mitotic cycles 
1-13 
 




6-7 2:50 - 3:10 h Gastrulation 
 
8-11 3:10 - 7:20 h Germ band elongation 
 
12-13 7:20 - 10:20h 





Head involution, dorsal 






Chapter 1    Introduction 
 7 
1.2 Muscle development: 
The flight of the bumble bee, the sprint of a cheetah, the agility of a gymnast 
and the no less remarkable movements we make in our daily lives, attest to the 
precision with which muscle patterns are laid down during animal development. 
Muscles have multiple roles in organisms, ranging from facilitating movement, to 
maintaining posture, stabilizing joints, shock absorption, respiration and moving 
substances within the body. In addition they aid the digestive process by peristalsis 
and are also essential for pumping blood through the body. In order to successfully 
carry out these diverse functions, muscles must develop correctly. Defects in muscle 
development and maintenance lead to debilitating disorders often ending in death. The 
right muscle type has to be specified at the right position, achieve and maintain 
correct size and possess a correctly ordered contractile apparatus which is capable of 
responding to various external and internal stimuli. Muscle morphogenesis is a 
multistep process involving myoblast specification and fusion, myotube extension, 
guidance and epidermal attachment, in addition to the organization of contractile 
proteins.   
1.2.1 Myogenesis in vertebrates: 
Vertebrate muscles, as in Drosophila, develop from the mesoderm though the 
development and organisation of the vertebrate skeletal musculature is far more 
complex compared to that of the fly. All skeletal muscles of the vertebrate body 
together with some of the head are derived from the somites which are transient 
structures derived from the paraxial (present on either side of the neural tube) 
mesoderm. The first step is the formation of a scaffold of relatively small 
multinucleate primary fibres that arise by myoblast fusion (Wigmore and Evans, 
2002). Subsequently secondary fibres are added alongside the primary fibres as the 
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muscles grow.  A population of cells (satellite cells) are kept aside as a reservoir for 
subsequent growth and repair. A single vertebrate muscle consists of many muscle 
fibres similar to adult Drosophila somatic muscles (Wigmore and Evans, 2002). The 
myogenic regulatory factors (MRF) like MyoD (functional equivalent of Drosophila 
Twist) and the MADS box transcription factor, myocyte enhancer factor 2, Mef2 
(DMef2 in Drosophila) are two amongst several factors critical for this process. It is 
fairly challenging to analyse vertebrate myogenesis, since developmental time spans 
are long, muscles are not always easily accessible and genetic interactions and 
signalling pathways are highly complex. Although the study of vertebrate model 
systems including cell lines has given us several insights into muscle development, 
the amenability of the Drosophila embryo has been cleverly exploited to reveal 
aspects of muscle biology that are more challenging to uncover in higher organisms.  
1.2.2 Drosophila as a model system to study myogenesis: 
There are many fundamental similarities between the biology of Drosophila 
and vertebrates. Genome sequencing projects have revealed that ~60% of Drosophila 
proteins share sequence similarity with human proteins (Rubin, 2001). Several 
Drosophila muscle specific genes are structurally and functionally conserved with 
those of vertebrates (Taylor, 1998). Also some principles of muscle development are 
similar (Abmayr et al., 2003; Baylies and Michelson, 2001). This genetic 
conservation is one among many reasons why Drosophila is regarded by many as a 
suitable model organism for the analysis of muscle development. In addition, the body 
wall muscles of the fly embryo are superficially located and easy to visualise. 
Embryonic muscle patterns are fairly simple and regular hence detecting defects in 
patterns or other developmental aspects of myogenesis is relatively easy. The 
availability of suitable muscle specific antibodies greatly aids in characterising mutant 
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phenotypes. The muscles of the embryo, larva and the indirect flight muscles of the 
adult have been instrumental in revealing developmental mechanisms of muscle 
development. 
In addition, the Drosophila S2 (or SL2) cell line derived from a primary 
culture of late stage (20-24 hour) embryos, has been widely used to study biochemical 
interactions between various myogenic factors. This versatile cell line grows rapidly 
at room temperature without CO2 and is easily adapted to suspension culture.   
1.2.3 Muscle types and muscle pattern of Drosophila: 
Drosophila myogenesis proceeds from the definition of the mesoderm in the 
early embryo, through the selection of muscle progenitors, to myoblast specification 
and fusion to final differentiation and maturation of the muscles. While the larva 
engages in burrowing and crawling activities, the adult engages in more complex 
behaviours like walking, flying, courtship and mating and in the case of the female, 
egg laying. Given these diverse behaviours and requirements, the larval muscles (also 
referred to as embryonic muscles) differ from the adult muscles.  
There are 4 major types of musculature in Drosophila, the somatic/body wall 
musculature, visceral musculature, cardiac musculature, the somatic gonad and the fat 
body. Each of these has a specialised function and hence a specific pattern and 
developmental process. Some details are described in the following sections  
1.2.4 Embryonic/larval musculature: 
1.2.4.1 Somatic musculature: 
During its 22hour embryogenesis the fruit fly constructs an intricate pattern of 
muscles that insert into the body wall of the developing embryo. They line the body 
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wall below the epidermis and are hence also called body wall muscles. Each muscle is 
a single syncytial (multinucleate) fibre formed by the fusion of myoblasts. Each 
possesses a characteristic size, shape, sites of epidermal attachment and points of 
motor neuron innervation. These muscles are formed in the embryo in a segmentally 
reiterated pattern and begin to display their contractile nature at stage 16-17 of 
embryogenesis and are fully functional in the larva. The organisation of these muscles 
is well suited for burrowing and crawling through a soft substrate, by peristalsis, a 
wave of segmental contraction that passes over from the front to the back of the body. 
To identify individual muscles both a numbering system and a lettering system are in 
use (Figure 1.3) (Bate, 1990; Bate, 1993). They are present in two layers one above 
the other. The organisation of the muscle pattern in the head, thorax, abdomen and tail 
segments are different. The abdominal pattern of the musculature in the fully 
developed embryo is identical to that in the third instar larva (Crossley, 1978). This 
thesis focuses only on the abdominal segments that forms the major part of the 
embryonic/larval body wall.  



























Figure 1.3 Embryonic somatic muscle pattern 
(A) The Drosophila embryo at stage 16-17 displays a well defined pattern of ~30 
somatic muscles in every hemisegment that are segmentally reiterated. Adapted from 
(Schnorrer and Dickson, 2004). (B) Schematic representation of somatic muscles in 
one abdominal hemisegment. These muscles occupy fixed positions along the dorso-
ventral and antero-posterior axis. Each is a syncytia. They are classified into dorsal, 
lateral and ventral groups. Colours indicate position from exterior to interior. 
Superficial/exterior muscles (red), intermediate (purple) and interior (green). They are 
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1.2.4.2 Visceral musculature: 
The visceral musculature comprises thin layers of muscle fibres surrounding 
the digestive tract which consists of the foregut, midgut and hindgut. The main 
portion of the digestive tract is represented by the midgut which consists of an inner 
layer of binucleate circular muscles and an outer layer of multinucleate longitudinal 
muscles. Unlike the midgut, the foregut and hindgut are surrounded only by circular 
muscles. The anterior segment of the digestive tract forms the mouth parts and the 
pharynx which are used to suck up liquid food.  
1.2.4.3 Cardiac musculature: 
In the larva the dorsal vessel, is a fairly simple structure. It is a continuous 
tube of mesodermal cells that runs beneath the dorsal midline of the epidermis from 
A8 (posteriorly), to the head (anteriorly) where it terminates dorsal to the brain 
hemispheres. A posterior chamber, the heart, pumps haemolymph anteriorly through 
two closely apposed cellular tubes, the aorta, as the heart contracts. From A1-A8 the 
cells of the dorsal vessel are principally of two kinds: the inner cardial cells forming 
the central tube and the pericardial cells alongside it. The cardiac musculature is 
uninucleate.  
1.2.4.4 Gonadal mesoderm: 
These basket shaped non syncytial structures are closely associated with the 
developing fat body. They consist of a small group of cells that contain and hold the 
germ cells together as a cluster. The gonadal mesoderm is crucial for gonad 
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coalescence. Germ cells remain scattered if the gonadal mesoderm is dysfunctional 
(Brookman et al., 1992).  
1.2.4.5 Fat body: 
The fat body is a relatively simple structure consisting of a bilaterally 
symmetrical monolayer of cells lying between the gut and the somatic musculature. It 
is a dynamic tissue involved in fat storage, energy metabolism and also in other 
critical biological functions like nutrient sensing and signaling to regulate the growth 
of tissues in response to nutrient availability.  
1.2.5 Adult musculature: 
Adult somatic muscles are formed by the fusion of myoblasts that are set aside 
in the embryo and proliferate during larval life. During metamorphosis the larval 
musculature is almost completely histolysed. At the same time a new set of adult 
muscles is formed from the pool of myoblasts that remained undifferentiated during 
embryonic and larval life. The adult muscle pattern of the abdominal segments is 
similar to the larval muscle pattern, but the muscles of the thoracic segments and the 
newly formed head are highly modified to function in feeding, locomotion, mating 
and sensory reception. Another major difference is the fibre number. In the larva each 
somatic muscle is a single multinucleate fibre whereas in the adult fly each muscle is 
a collection of fibres (similar to vertebrate skeletal muscles). 
1.3 Mesoderm formation in the Drosophila embryo: 
All muscles develop from the mesoderm. The morphology of the newly laid 
Drosophila embryo already reflects a dorso-ventral polarity since it is flattened on the 
dorsal side and curved on the ventral side. At the blastoderm stage the Drosophila 
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embryo can be divided into three broad territories. The dorsal cells of the embryo 
gives rise to the dorsal ectoderm, the lateral cells form the neuroectoderm and the 
ventral cells constitute the mesoderm. As the embryo gastrulates these ventral cells 
invaginate and migrate dorsally to lie adjacent to and under the ectoderm (Leptin and 
Grunewald, 1990). The muscles of the body wall, gut (visceral muscles), heart and fat 
body arise from these cells (Bate, 1993) 
1.4 Development of the larval somatic musculature: 
During embryogenesis the mesodermal cells undergo a series of movements, 
cell fate decisions and morphological changes to create the complex pattern of ~30 
muscles per abdominal hemisegment. In the early stage 12 embryo, the mesoderm 
forms a loose, multilayered sheet of cells that splits into a number of different organ 
primordia. The superficial layer contains the myoblasts of the somatic musculature 
(sm) (Figure 1.4). In this layer, cellular aggregates of early differentiating myoblasts 
start to appear. Each muscle is a syncytium formed by the fusion of two distinct types 
of myoblasts, a founder cells (FC) and several fusion competent myoblasts (FCM) 
from stage 12-15. As dorsal closure and head involution occur at stage14-15, 
individual muscle fibres become distinguishable by their characteristic rectangular 
shape. A schematic depiction of the fully developed larval muscle pattern of a stage 
17 embryo (Figure 1.4). While all muscles share general properties like structural and 
contractile proteins and neurotransmitter receptors, each muscle is unique in terms of 
its position, size, points of epidermal attachment and points of motor neuron 
innervation (Bate, 1993; Bernstein et al., 1993). Some main events of somatic muscle 
development are summarised in Figure 1.5. 
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Figure 1.4: Development of the embryonic somatic muscle pattern  
(Adapted from (Hartenstein, 1993).  Two distinct myoblasts classes, the FC and FCM, 
are specified around stage 12 following which myoblast fusion occurs until stage 15 
giving rise to the stereotypic pattern of ~30 syncitial muscles in every hemisegment. 












Figure 1.5: Summary of mesodermal events in relation to general cell movements  
These events lead to the formation of the somatic muscle in the embryo. Time in hrs 
after egg laying (AEL) is indicated along with embryonic stage (red). 
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1.4.1  Myoblast specification: 
Initially all mesodermal cells express uniform levels of the transcription factor 
Twist (Twi) (Thisse et al., 1988) and its immediate targets Tinman (Bodmer et al., 
1990; Yin et al., 1997) and Drosophila-Myocyte enhancer factor 2 (DMef2) (Lilly et 
al., 1994; Nguyen et al., 1994; Taylor et al., 1995). Twi expression is progressively 
refined after germ band extension, into alternate high and low Twi expressing stripes. 
Low Twi levels mark the visceral and cardiac primordium whereas high Twi levels 
demarcates the somatic muscle primordium. From amongst the high Twist expressing 
cells, a cluster of equivalent cells (“promuscle group”) expressing the basic helix loop 
helix protein, Lethal of Scute (L’sc) is specified (Carmena et al., 1995). L’sc 
expression is progressively restricted by lateral inhibition through the actions of 
neuorgenic genes like Notch and Delta, to one cell in the cluster, the progenitor, 
around stage 10 (5hAEL) of embryonic development (Carmena et al., 1995). The 
progenitors move into close contact with the ectoderm and divide asymmetrically, 
giving rise to two distinct founder cells (FCs) or one founder and the precursor of an 
adult muscle (Carmena et al., 1995; Carmena et al., 1998; Ruiz Gomez and Bate, 
1997). Proteins known to have critical functions during neural asymmetric cell 
divisions, like Inscuteable (Insc), an adapter cytoskeletal protein and Numb, a 
membrane associated protein, localise as cortical crescents on opposite sides of the 
dividing progenitor (Guo et al., 1996; Ruiz Gomez and Bate, 1997) and function in 
the asymmetric division of the progenitor. While the progenitor gives rise to two FCs, 
the remaining cells in the equivalence group form the FCMs. FCs are located at 
specific positions along the hemisegment, marking the position of the future muscle. 
These initial events are summarised in Figure 1.6 while more general events are 
summarised in Figure 1.5. 
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1.4.2 The founder cell hypothesis and muscle identity genes: 
While much is known about the specification of progenitors and FCs little is 
understood about how information in a founder gives rise to specific muscle traits. 
Pioneering work by Michael Bate and colleagues led to the formulation of the founder 
cell hypothesis which states that each FC contains all the information for the 
development of a particular muscle. FCMs in contrast have been considered a more 
homogenous population of cells that contribute to muscle size by fusing with the FC. 
The FCM nuclei get entrained to a particular muscle programme upon fusion with the 
FC (Bate, 1990).  It is known that specific combinations of signalling inputs received 
by an FC result in the production of a unique set of molecular determinants, encoded 
by the founder cell identity genes, that gives each muscle its shape, size, position and 
motor neuron connection pattern. These genes have been called muscle identity genes 
by virtue of the fact that they identify, by their expression pattern, specific FCs and 
hence specific muscles. Eleven identity genes have thus far been identified that 
include Even skipped (Eve) (Frasch et al., 1987) and Kruppel (Kr) (Ruiz-Gomez et 
al., 1997). These genes are expressed in different sometimes overlapping subsets of 
FCs. A gene is called a founder identity gene if it fulfils the following criteria:  
• It encodes a transcriptional regulator 
• It is expressed in a subset of FCs 
• It has a known or presumed role in specifying the developmental fates 
of individual muscles, leading to complete and/or partial 
transformations in muscle identity. 
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Both the overlapping pattern of FC identity gene expression in different sets of 
muscle FCs and genetic analysis have led to the hypothesis that individual muscle 
identities are specified by combinatorial codes of identity genes. Results from loss 
and gain of function experiments revealed added complexity to the possible roles of 
these genes. It was hypothesised that these transcriptional regulators may target 
different aspects of the morphogenetic process in different founder cells. Some 
founder cell identity genes may control other FC transcriptional regulators whereas 
others appear to control directly specific attributes of muscle morphogenesis (Ruiz-
Gomez et al., 1997). A critical test of the founder cell hypothesis was provided by 
embryos where myoblast fusion fails. In the absence of fusion the FCs form at 
appropriate locations, express their normal complement of genes and go on to 
differentiate as mononucleate “mini muscles”. These miniature fibres are correctly 
innervated and contractile (Rushton et al., 1995). The unfused FCMs express the 
muscle protein myosin but do not differentiate to form muscle and eventually 
degenerate (Rushton et al., 1995). Thus, where myoblast fusion fails the FCs are 
revealed as a special class of cells that uniquely have access to the information 
necessary to a) complete myogenesis and b) to execute the specific programme of 
differentiation characteristic of the muscles whose formation they seed (Baylies et al., 
1998). Recently a large scale gene expression analysis identified about 83 genes 
differentially expressed in FCs and FCMs. The array data indicate that these two 
groups of myoblasts have distinct transcriptional profiles and raise the possibility of a 
greater role for FCM in determining final muscle morphology (Artero et al., 2003). 
The mechanisms underlying the complex morphological changes that occur during 
migration and fusion as well as changes in cell shape and physiology likely require a 
dynamic programme of transcriptional activity. 
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1.4.3 The process of myoblast fusion: 
Membrane fusion is a universal process that encompasses a variety of events 
from exocytosis at the synapse to the entry of small viruses into host cells to the 
formation of large muscle syncytia. Despite this diversity all fusion reactions 
comprise an elementary process that includes membrane contact, membrane merger 
and the opening of an aqueous fusion pore. Several distinct events occur in the 
developing myoblasts to achieve cell fusion, summarised in the schematic Figure 1.7. 
The process of myotube/myofibre formation is initiated when the FCs and FCMs 
differentiate. Recent studies have shown that myoblasts are spatially organised in the 
embryo. A three dimensional map has demonstrated the relative position of many FCs 
within a single mesodermal hemisegment as fusion begins (Beckett and Baylies, 
2007). This has shown that the characteristic FC groupings of dorsal, lateral and 
ventral regions are maintained throughout fusion and correspond to the final muscle 
pattern. The myoblasts become competent to fuse and express genes associated with 
the fusion process. The FCs express the myoblast attractants, Dumbfounded 
(Duf)/Kin of irregular-chiasm-C (Kirre) and its paralogue Roughest (Rst)/Irregular 
chiasm-C (IrreC) (Bate, 1990; Strunkelnberg et al., 2001), in addition to the muscle 
identity genes (Bate, 1990). The FCMs on the other hand constitute a more 
homogeneous population of cells expressing the Duf/Rst ligands, Sticks and Stones 
(Sns) (Bour et al., 2000) and Hibris (Hbs) (Artero et al., 2001). The FCMs contribute 
to muscle size by fusing with the FCs (Bate, 1990; Rushton et al., 1995).  
Duf/Rst expressed on the FC surface and Sns/Hbs expressed on the FCM 
surface are thought to bring about myoblast attraction, and have been suggested to 
actively participate in this process (Artero et al., 2001; Bour et al., 1995; Dworak et 
al., 2001; Strunkelnberg et al., 2001). Fusion always occurs between an FC/myotube 
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and FCM and never between cells of the same type (Baylies et al., 1998). Pioneering 
work by Doberstein et al. used transmission electron microscopy to examine myoblast 
fusion at the ultrastructural level (Doberstein et al., 1997). Upon FC-FCM contact and 
adhesion, the presence of vesicles has been observed at the site of adhesion prior to 
membrane breakdown. These vesicles appear to align with each other to form “paired 
vesicles”. The content of these vesicles is unknown. It is inferred that vesicles appear 
in both FC and FCM as well as in the developing myotubes and associated FCMs. 
After alignment the vesicles are thought to resolve into prefusion complexes that later 
resolve into plaques (Doberstein et al., 1997). These plaques are reminiscent of 
structures identified in fusing vertebrate myoblasts (Rash and Fambrough, 1973). This 
is accompanied by the elongation of the aligned myoblasts to maximise contact 
points. Multiple pores are observed in the fusing membranes adjacent to the electron 
dense plaques (Doberstein et al., 1997). This morphology suggests that fusion occurs 
at multiple sites along the apposed membranes. The fusion process is completed as the 
membrane vesiculates and is removed. Cytoplasmic continuity leads to the formation 
of a multinucleate syncytium (Abmayr et al., 2003). Further studies have revealed the 
accumulation of an F actin focus (FuRMAS) at the site of myoblast adhesion (Kesper 
et al., 2007). Live imaging data indicates that the F-actin focus marks the site of 
fusion (Richardson et al., 2007). Proteins like Duf and Sns localise to this focus 
suggesting that this might be their site of activity during fusion (Kesper et al., 2007).  
The process of fusion is reiterative. Fusion initiates between an FC and FCM 
that are in its vicinity leading to the formation of a bi/trinucleate precursor. As 
development proceeds, FCMs appear to migrate towards the precursor for further 
rounds of fusion Figure 1.7. (Beckett and Baylies, 2007). Events are repeated in a 
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stepwise manner first leading to the formation of a bi/trinucleate precursor, followed 
by additional rounds of fusion between precursors and FCMs, accompanied by growth 
at the ends of the myotube. Every round of fusion appears to involve 2-3 FCMs and 
subsequent intracellular events that likely contribute to the reorganisation of the 
cytoskeleton. Upon fusion, the nuclei of the FCMs are entrained by the FC nucleus 
and begin to express FC specific molecules (Bate, 1993). The smallest muscles of the 
embryo are formed by the fusion of as little as 3-5 cells whereas the larger muscles 
are formed by the fusion of ~30 cells. As embryogenesis proceeds the newly formed 
muscles attach to specific sites at the epidermis (Bate, 1990). Figure 1.6 and Figure 
1.7 summarise the above sections. 







Figure 1.6: Outline of somatic muscle development.  
L’sc specifies the equivalence group (pink) that leads to the formation of the 
progenitors by lateral inhibition. These divide asymmetrically to give different FCs 
and the adult precursors (blue, purple, green, orange). Cell fusion and terminal 









Figure 1.7: Process of myoblast fusion  
This is a multistep unidirectional process. Competence of myoblasts leads to 
recognition between FC and FCMs due to molecules like Duf and Sns that are 
expressed on their respective surfaces. Adhesion leads to a series of membrane events 
eventually leading to membrane breakdown and cytoplasmic continuity between the 
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1.4.3.1  Molecules required for myoblast fusion: 
Genetic screens have identified a large number of molecules required for 
myoblast fusion that fall into several categories depending on their predicted 
functions (Richardson et al., 2008a; Richardson et al., 2008b). Mutation of these 
genes, in most cases, leads to the formation of defective “mini muscles” with reduced 
nuclei, ending in embryonic lethality. Duf and Rst are Type I single pass 
transmembrane receptors with an N terminal extracellular domain and C terminal 
intracellular domain, belonging to the Immunoglobulin superfamily of proteins and 
are expressed specifically in the FC or growing myotube (Menon et al., 2005; Ruiz-
Gomez et al., 2000). Their function is redundant in the FC. Duf and Rst interact with 
the FCM specific protein, Sns. These proteins seem to be the main mediators of 
myoblast adhesion. In mutant embryos that lack both duf and rst, Df(1)w67k30 
(henceforth called the duf,rst mutant), there is no attraction and adhesion between FCs 
and FCMs leading to a complete block in fusion and the presence of mononucleate 
mini muscles (Ruiz-Gomez et al., 2000; Strunkelnberg et al., 2001). On the other 
hand, sns mutants have been reported to show single fusion events (Menon et al., 
2005). Both the extracellular and intracellular domains of Duf have been shown to be 
critical for the attraction of FCMs and sustenance of fusion respectively (Menon et al., 
2005).  
Rolling pebbles (Rols7)/Antisocial (Ants), a scaffold protein with multiple 
protein interaction domains, is involved in sustaining fusion beyond the bi/trinucleate 
precursor stage. Fusion in rols mutant embryos stalls at this precursor stage (Chen and 
Olson, 2001; Menon and Chia, 2001; Rau et al., 2001). On the other hand, Loner, an 
Arf6 guanine nucleotide exchange factor (GEF), has been reported to be involved in 
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the initial stage of fusion with minimal fusion occurring in a loner single mutant. 
Binucleate precursors are observed (Beckett and Baylies, 2007; Chen et al., 2003). 
Rols7, henceforth called Rols, and Loner have been shown to respond to Duf and 
translocate to points of cell contact in a Duf dependent manner (Chen et al., 2003; 
Menon et al., 2005). Both Rols and Loner colocalise with Duf but do not colocalise 
with each other suggestive of functions in different pathways (Chen et al., 2003; 
Menon et al., 2005). Rols is thought to physically link Duf to elements of the 
cytoskeleton namely D-Titin, a muscle structural protein (Zhang et al., 2000) and 
Myoblast city (Mbc), the Drosophila Dock180 homologue (Erickson et al., 1997; 
Menon et al., 2005), in addition to replenishing Duf at the surface of the precursor 
thereby sustaining fusion (Menon et al., 2005). Arf6 has been shown to perform 
several roles including the regulation of Rac, an actin regulating protein (Donaldson, 
2003; Radhakrishna et al., 1999). Consistent with this function Rac is mislocalised in 
loner mutants (Chen et al., 2003). It has been shown that Loner has a specific GEF 
activity on Arf6, but not Arf1 in vitro, and the overexpression of a dominant negative 
GDP-bound Arf6 mutant partially phenocopies loner mutants (Chen et al., 2003). 
Curiously, the arf61 null mutant has a normal wild type (WT) musculature (Dyer et 
al., 2007). This suggests that the real target of Loner is another GTPase or a second 
redundantly acting target (Dyer et al., 2007), although Drosophila has no second arf6 
gene (Lee et al., 1994). It has been suggested that the Rols-Mbc and Loner pathways 
function in parallel and converge onto Rac (Chen et al., 2003). While myoblast 
attraction and fusion have been suggested to be mediated by interaction between Duf 
and Sns (Galletta et al., 2004), downstream events that lead to changes in the 
cytoskeleton are still unresolved. 
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Genetic analysis has also highlighted the critical role of the actin cytoskeleton 
and its regulators in the fusion process, which is not discussed in this thesis. 
1.4.3.2  Models of myoblast fusion: 
Previous studies have proposed a two-step model of myoblast fusion. In the 
first step, a bi- or trinucleate precursor is formed and then, in the second step, all 
subsequent fusion events occur until the muscle reaches its final size (Rau et al., 2001; 
Schroter et al., 2004). This model also suggests that distinct gene products and 
subcellular events, as analysed by transmission electron microscopy, are required for 
each step of the fusion process. In the first step that leads to the formation of a 
bi/trinucleate precursor molecules like Duf and Rst are required while the second step, 
which consists of subsequent rounds of fusion, requires molecules like Rols, functions 
predicted by the phenotype of these mutants (Chen and Olson, 2001; Menon and 
Chia, 2001; Rau et al., 2001; Ruiz-Gomez et al., 2000; Strunkelnberg et al., 2001) 
(Figure 1.8).  
The recent re examination and quantification of the fusion profile of individual 
muscles in fusion mutants provides evidence that is not fully consistent with the two 
step model (Beckett and Baylies, 2007). This analysis demonstrated the following, 1) 
Even fusion mutants like mbc, initially characterized to completely block fusion, do 
display occasional fusion events (Beckett and Baylies, 2007; Rushton et al., 1995), 2) 
The rare fusion events that do occur in the fusion mutants analyzed can occur at any 
stage of myoblast fusion, not just during early fusion (Beckett and Baylies, 2007), 3) 
In those fusion mutants in which two to three fusion events per FC frequently occur 
like in the case of rols, there are also cases of FCs in which no fusion occurs, 
demonstrating that these gene products can be required for both the initial or later 
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fusion events (Beckett and Baylies, 2007). Thus the 2 steps in myoblast fusion may 
not be molecularly distinct. Instead, less frequent fusion events between FCs and 
adjacent FCMs might occur initially followed by more frequent events in the later 
stages as FCMs migrate towards the growing myotube, giving rise to two temporal 
phases of fusion and that all gene products required for the early phases are likely also 
required for the later phases of fusion (Figure 1.9).  







Figure 1.8: Two step model of myoblast fusion 
The first step leads to the formation of the bi/trinucleate precursor and requires Duf 
and Rst. The 2nd step includes subsequent rounds of fusion which require molecules 










Figure 1.9: Two phase model of myoblast fusion 
All fusion events are subcellularly and molecularly equal. An earlier infrequent fusion 
phase is followed by a later frequent fusion phase. The switch from one phase to the 
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1.4.4 The Sarcomere: 
Terminal muscle differentiation leads to the organisation of the contractile 
apparatus. The sarcomere is the basic contractile unit, repeated along the length of the 
differentiated muscle. It consists of highly conserved contractile proteins like actin, 
myosin and their associated proteins. Muscles display characteristic striations in the 
larva and adult due to this ordered alternating array of actin and myosin filaments. 
The organisation of this unit is visible from stage 17 onwards, prior to embryo 
hatching and is better defined and fully functional in the larva and later in the adult. 
The organisation of the sarcomere is critical for muscle contraction (Figure 1.10). 
Muscles contract when actin and myosin filaments slide against each other. The 
sarcomere generates and transmits the contractile force to the muscle membrane via 
other cytoskeletal elements that link the sarcomere to the muscle membrane. 
1.4.5 Muscle attachment: 
As the myotubes grow in size through cell fusion, they also have to find their 
proper attachment positions in the epidermis. Each myotube attaches itself to a 
specific tendon cell thus establishing the connection with the endoskeleton (in 
vertebrates) or the exoskeleton (in invertebrates). A precise match between somatic 
muscles and their attachment sites is critical for muscle function and hatching of the 
embryo (Figure 1.11). This is achieved by continuous dialogues between the muscles 
and the tendon cell precursors. At stage 13 soon after the first myoblasts have fused, 
myotubes begin to search for their future attachment sites. The myotubes form 
extensive filopodia mainly located at the two opposite ends of the cell. They 
presumably sense their environment for guidance cues. For some myotubes one end is 
already close to its attachment site whereas the other often has to move across longer 
distances (Schnorrer and Dickson, 2004). The tendon cell precursors guide the 
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extending muscle to migrate towards them.  Once the myotubes reach the tendon cell 
precursor, it localizes many adhesion complex molecules in order to form a stable 
adhesion complex (Brown et al., 2000). Following this association the myotube 
provides a differentiation signal to the tendon precursor cell driving its maturation to 
form the tendon cell. It now assumes the familiar rectangular shape ready for 
contraction (Bate, 1990; Schnorrer and Dickson, 2004). It is remarkable that fusion in 
the center of the growing myotube and extension and migration at the ends of the 
myotube are so well coordinated. Signalling between these two cell types leads to 
cytoskeletal reorganisation allowing the muscle to contract and the tendon cell to 
withstand this contractive force.  
A key factor in tendon cell differentiation is the zinc finger transcription factor 
Stripe (Sr) whose activity is necessary and sufficient to induce the fate of tendon cells. 
(Becker et al., 1997; Frommer et al., 1996; Vorbruggen and Jackle, 1997). Initially sr 
is induced solely by epidermal cues independent of muscle and is also regulated post 
transcriptionally by the RNA-binding protein, Held out wing (How) (Nabel-Rosen et 
al., 1999) that is expressed in both muscle and tendon cell. How mRNA is spliced to 
produce two isoforms, the long How(L) and the short How(S) (Nabel-Rosen et al., 
1999). In early tendon precursors only How(L) is expressed which results in 
degradation of sr mRNA and hence low levels of Sr. 









Figure 1.10: Muscle contractile unit.  
(A) Larval muscle striations as visualised with antibodies against Myosin heavy chain 
(MHC). (B) Insect muscle fibre showing alternate dark and light striations of the 
sarcomere. (C) The sarcomere comprises actin and myosin that slide against each 
other between two Z lines. During muscle contraction the distance between two Z 
lines becomes shorter though the length of individual filaments remains constant. 
 
Figure 1.11: Muscle attachment  
(Adapted from (Volk, 1999). Communication 
between muscle (green) and tendon cell precursor 
leads to tendon cell differentiation (red) and stable 




Neuromuscular Junctions.  
Each muscle is innervated by specific motor neurons 
that form synapses at specific points on the muscle 
membrane. Shown are some axons of the transverse 
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As the myotubes extend they secrete the neuregulin-like ligand, Vein, which 
becomes enriched at the muscle-tendon cell junctions and signals through the 
epidermal growth factor (EGF) receptor to the tendon cell precursors (Yarnitzky et al., 
1997). This constitutes the second phase of tendon cell differentiation. Vein signalling 
from the myotubes induces How(S) in the tendon precursors which competes with 
How(L) for sr mRNA and results in its stabilisation. Only those tendon cells that 
receive the Vein signal will express markers of terminally differentiated tendon cells 
(Becker et al., 1997; Yarnitzky et al., 1997).  Therefore it is implied that the switch 
between How(L) and How(S) may serve as a switch between the tendon precursor 
stage and the mature tendon cell.  
1.4.5.1 The requirement of muscle tendon junctions for proper muscle function: 
The formation of stable adherence junctions between the muscle and its 
corresponding tendon cell is essential to anchor the muscles to the epidermis and to 
withstand the forces of muscle contraction. These junctions are required to translate 
muscle contraction into movement of the exoskeleton. Hemi-adherence junctions are 
formed between the muscle and the extracellular matrix (ECM) secreted into the 
space between the muscle and the tendon cell. Similar junctions form between the 
tendon cell and the same ECM material. The formation of these junctions is mediated 
by the Drosophila integrin adhesion receptors. Integrins are required to anchor the 
ends of the actin filaments in the growing myotube to the ECM (Delon and Brown, 
2007). In the absence of functional integrins, such as in myospheroid homozygous 
mutants, the muscles approach the tendon cells and form an initial contact 
(presumably mediated by cell-cell adhesion molecules like cadherins) but following 
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the initial muscle contractions (at embryonic stage 16-17) the muscles detach and 
round up (Brown, 1993; Leptin et al., 1989; MacKrell et al., 1988). The functional 
characterization of other integrin subunits and downstream effectors of integrin 
signals has underscored the importance of this pathway in establishing muscle 
attachment sites (for review see Bokel and Brown, 2002). 
1.4.6 The neuromuscular junction: 
The Drosophila neuromuscular junction (NMJ) comprises synaptic 
connections between motor neurons and contact points on the muscle. Abdominal 
hemisegments from A2-A7 that comprise ~30 somatic muscles each, are innervated 
by about 35 individually identifiable motorneurons in a highly stereotyped and 
segmentally reiterated manner. Motor neuron cell bodies and dendrites are located in 
the central nervous system along the ventral midline, while the axons project to their 
muscle targets. Motor neuron innervation plays no role in the patterning, 
morphogenesis, maintenance or physiological development of the somatic muscles in 
the embryo (Broadie and Bate, 1993b) although it is required for the localization of 
neurotransmitter receptors at the post synaptic muscle site during synapse maturation 
(Broadie and Bate, 1993a). While there is no obvious relationship between muscle 
location and motor neuron cell body position within the CNS, the neuron dendrites are 
anatomically segregated in a way that reflects the position and orientation of the 
muscles they innervate (Landgraf et al., 1997; Landgraf et al., 2003). Most motor 
axons exit the CNS via a common lateral exit point and then split into two main 
nerves, the intersegmental nerve (ISN) which innervates the dorsal muscle field and 
the segmental nerve (SN) which innervates the ventral muscle field. The smaller 
transverse nerve (TN) exits the CNS dorsally and innervates a few muscles in the mid 
body wall (Figure 1.12) (Keshishian et al., 1996). Upon exiting the CNS groups of 
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axons defasciculate at specific choice points to form the five major branches of the 
embryonic motor projection. These axons remain fasciculated within each nerve 
branch until the target muscle domain is reached and then begin to defasciculate from 
one another as they contact their individual target muscles.  
Ablation experiments have shown that the presence of a specific muscle fibre 
is not required for motor neurons to reach they target site at stage 13-14, indicating 
that the initial process of axon outgrowth is not dependent on guidance cues provided 
by the target muscle (Cash et al., 1992; Sink and Whitington, 1991). The pattern of 
axonal outgrowth is molecularly determined by the complement of proteins that each 
motor neuron expresses along with the interpretation of guidance cues it receives from 
the environment and the musculature. Correct axon pathfinding brings the motor 
neurons to the appropriate target region following which growth cones probe the 
surface of nearby muscle fibres, withdraw inappropriate contacts and form stable 
synapses with correct targets. If a motor neuron’s normal target muscle is absent, the 
motor neuron grows to the correct target area but initially fails to form synapses on 
alternate muscle fibres. However ectopic synapses form eventually on neighbouring 
muscles (Cash et al., 1992; Sink and Whitington, 1991). This implies that specialised 
molecular recognition events occur between individual growth cones and their muscle 
targets yet the motor neuron retains some degree of flexibility and is able to form 
connections with alternative partners in the absence of its preferred targets. It is 
interesting that the suppression of electrical activity also results in the formation of 
ectopic motor neuron contacts (Jarecki and Keshishian, 1995). 
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1.4.7 Muscle integrity: 
Maintenance of muscle organization is critical for its function and often for the 
survival of the organism. Muscle wasting is defined as a weakening, shrinking, and 
loss of muscle caused by disease or lack of use. Muscle wasting decreases strength 
and the ability to move. In humans muscle wasting or atrophy is caused by the natural 
factor of ageing or disease factors that are often genetic. Several such conditions lead 
to muscle atrophy either due to degenerating motor neurons and neuromuscular 
junctions, that secondarily affect muscle function and integrity or conditions that 
affect the muscle directly.  
Some factors have been identified in Drosophila that are required for the 
maintenance of muscle mass and integrity. Mutations in sarcomeric components like, 
troponin (Nongthomba et al., 2004), and muscle LIM protein at 84B (mlp84B) (Clark 
et al., 2007) lead to defects in sarcomeric organisation and muscle contraction both of 
which affect muscle integrity in the pupa/adult. Mutations in integrin subunits (eg. 
myospheroid), cause weak and unstable muscle-tendon interactions. After the initial 
contractions the muscles detach and round up ending in embryonic lethality. The loss 
of mind bomb2 (mib21) a RING finger protein, leads to, embryonic muscle 
detachment and massive muscle degeneration (Nguyen et al., 2007). Studies 
performed in embryos and larvae have revealed that Mib2 might have a structural role 
in maintaining sarcomere stability, failing which the myotubes apoptose (Carrasco-
Rando and Ruiz-Gomez, 2008; Nguyen et al., 2007). mib2 RNAi analysis have shown 
that sarcomeres in the adult muscles are poorly defined and often disintegrate. The de-
regulation of gene regulatory cascades required for the maintenance of muscle 
features could result in structurally weak muscles and muscle wasting.  
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1.5 Chromatin organisation: 
In eukaryotic cells DNA is folded with histone and non histone proteins to 
form chromatin. Each chromatin unit or nucleosome contains 146 bp of DNA 
wrapped around an octamer of histones (Luger et al., 1997). In every cell there exists 
a dynamic balance between genome packaging and genome access. Spatial and 
temporal regulation of gene expression is critical for achieving normal body 
development, organogenesis, and cell differentiation. Molecular signals that 
determine on or off states of transcription may be transient, but resulting decisions 
about cell identity or differentiation are long-lived. This requires cross talk between 
the transcriptional machinery and complexes involved in regulating chromatin status. 
Chromatin remodeling complexes and histone modifying enzymes are components of 
intricate epigenetic mechanisms that help compact and organize genomes into discrete 
chromatin domains (Goll and Bestor, 2005; Jenuwein and Allis, 2001). Chromatin 
comprises euchromatin which is less condensed, more accessible and generally more 
easily transcribed, and heterochromatin which is typically highly condensed and 
inaccessible (Huisinga et al., 2006). Heterochromatic regions that remain condensed 
throughout the cell cycle are referred to as constitutive heterochromatin. However, 
heterochromatin is also found at developmentally regulated loci, where the chromatin 
state can change in response to cellular signals and gene activity. These regions are 
referred to as facultative heterochromatin. A key feature of heterochromatin is its 
ability to propagate, and thereby influence gene expression. The spreading of 
heterochromatin generally causes epigenetic repression of nearby sequences, in a 
process that is referred to as silencing. Although epigenetic gene silencing is almost 
synonymous with heterochromatisation, there are several reports in which 
heterochromatin formation is required for activation of gene expression (Lu et al., 
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2000; Weiler and Wakimoto, 1995; Yasuhara and Wakimoto, 2006). Histone H3 
methylated at lysine 9 (me H3K9) and the heterochromatin protein HP1, which are 
necessary for the formation of heterochromatin, have been found in association with a 
subset of transcribed genes (Cryderman et al., 2005; Piacentini et al., 2003). In 
addition, it has been shown that heterochromatin proteins recruit factors that facilitate 
the access of RNA polymerase II to heterochromatic loci (Zofall and Grewal, 2006). 
These recent findings suggest that heterochromatin has multifaceted roles in diverse 
cellular functions that in some instances involve opposing cellular activities (Zofall 
and Grewal, 2006).  
1.5.1 Muscle associated chromatin changes: 
The development of such complex syncytia and their arrangement into a 
functional pattern requires a coordinated gene regulatory cascade. The multi-step 
process of skeletal muscle differentiation is accompanied by the transcriptional 
activation of several muscle-specific genes, and repression of genes associated with 
cell proliferation. Many of these changes are largely brought about by DMef2 in 
Drosophila and members of the MyoD family and Mef2 transcription factors in 
vertebrates. Chromatin re-modeling complexes and chromatin remodeling enzymes 
have been found to be associated with muscle specific loci in proliferating and 
differentiating vertebrate myoblasts. The modification of histones by the addition or 
removal of acetyl or methyl groups through the action of various chromatin modifying 
enzymes, have been implicated in the differentiation of muscles (McKinsey et al., 
2002). Many of these conclusions have been drawn from studies in skeletal muscle 
cell lines, which can be maintained as undifferentiated myoblasts and triggered to exit 
the cell cycle and differentiate into multinucleated myotubes upon the withdrawal of 
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mitogens. Recent analyses of genetically altered mice have begun to reveal additional 
functions for chromatin remodeling enzymes.(McKinsey et al., 2002)  
1.6  Histone pre-mRNA processing and the histone locus body (HLB): 
Histones and their modifications as well as other chromatin re-modeling 
complexes are thought to be components of intricate epigenetic mechanisms that 
organize genomes into discrete chromatin domains and also function in the regulation 
of gene expression (Boyer et al., 2004; Probst et al., 2009; Quina et al., 2006). A large 
body of evidence has indicated that histone synthesis is tightly coupled to DNA 
replication (Groth, 2009; Probst et al., 2009). Histone levels are primarily controlled 
by regulating histone mRNA abundance (Harris et al., 1991; Stauber and Schumperli, 
1988). Metazoan histone mRNAs are unique. Unlike polyadenylated mRNAs their 
3’end terminates in a stem loop rather than in a polyA tail (Marzluff, 1992). The 
processing of histone pre-mRNAs requires 2 cis elements, and a number of trans 
acting factors as depicted in Figure 1.13. The cis elements are a stem loop at the 3’end 
and an element downstream of the cleavage site called the histone downstream 
element (HDE) (Mowry and Steitz, 1987). Histone genes lack introns hence the only 
processing step required is the endonucleolytic cleavage of the pre-mRNA to form the 
3’end of the mature mRNA. The trans acting factors include the Stem Loop Binding 
Protein (SLBP) (Wang et al., 2006) or Hairpin Binding Protein (HBP) (Martin et al., 
1997) and the U7snRNP (Galli et al., 1983). These factors recruit a complex that 
triggers cleavage via CPSF23 between the stem loop and the HDE forming the mature 
histone mRNA (Dominski et al., 2005; Kolev and Steitz, 2005; Wagner et al., 2007). 
Defects in histone pre-mRNA processing lead to the formation of long polyA 
transcripts due to the presence of a cryptic polyA site downstream of the cleavage 
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site.  Drosophila SLBP (sSLBP) (Sullivan et al., 2001), U7snRNA (Dominski et al., 
2003) and the U7snRNP specific proteins Lsm10 and Lsm11 (Azzouz and 
Schumperli, 2003) have been identified as factors required for histone pre-mRNA 
processing (Godfrey et al., 2006; Godfrey et al., 2009; Sullivan et al., 2001).  
 U7snRNP particles have been shown to localize to the histone locus body 
(HLB), a distinct nuclear body that is often in close proximity to the Cajal body (CB) 
(Liu et al., 2006). The HLB is associated with the histone genes which are contained 
in a 5kb sequence present in ~100 tandemly repeated copies as schematised in Figure 
1.14 (Liu et al., 2006).  The HLB has been speculated to play multiple roles in 
assembly, modification, storage and delivery of the histone pre-mRNA processing 
machinery (Liu et al., 2006). 








Figure 1.13: Histone pre-mRNA processing in metazoans.  
This schematic depicts some components of the histone processing machinery that 
lead to cleavage of the histone pre-mRNA between the stem loop and the histone 













Figure 1.14: The histone locus body.  
This nuclear organelle comprises factors associated with histone pre-mRNA 
processing machinery. It is closely associated with the histone genes and often lies 
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To summarise the seemingly divergent topics presented in this section, this 
thesis presents a study of two aspects of Drosophila muscle development, myoblast 
fusion and terminal differentiation. The first part of the thesis presents work done on 
the myoblast attractant and key fusion molecule, Duf, and its requirements in carrying 
out efficient fusion. This is followed by a section on the new functions of Rols and 
Loner, molecules known to lie downstream of Duf, during myoblast fusion. In this 
section I also present evidence that supports a recent model of myoblast fusion. The 
second half of this thesis presents the characterisation of a novel mutant, muscle 
wasted (mute) that appears to be required for late events of muscle differentiation. 
Mute appears to be a novel component of the histone locus body and affects muscle 
differentiation possibly by influencing heterchromatic changes. 
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2 Materials and Methods 
2.1 Molecular Work 
2.1.1 Recombinant DNA methods 
General recombinant DNA methods were performed as described (Sambrook 
and Russell). All constructs were fully sequenced using automatic PCR-based Big-
Dye sequencing method. Polymerase Chain Reaction (PCR) was done with High 
Fidelity Taq DNA polymerase (Roche) for cloning. Hot Start Taq (Qiagen) was used 
for colony PCRs. All restriction enzymes were purchased from New England Biolabs 
(NEB). Restriction enzyme digestions were performed using appropriate buffers and 
BSA supplied by the manufacturers. Blunt ending of DNA fragments was carried out 
using Klenow DNA polymerase (large fragment, NEB). Dephosphorylation of DNA 
fragments was done using calf intestinal phosphatase (CIP, NEB). T4 DNA ligase 
(Promega) was used for ligation of DNA fragments. All ligations were transformed 
into competent E.coli cells unless indicated otherwise. Recovery after transformation 
was done in 1ml SOC media (super optimal broth with catabolite repression- 2% 
bacto-tryptone, 0.5% bacto-yeast extract, 8.56mM NaCl and 2.5mM KCl). 
2.1.2 Cloning strategies and contructs used in this study 
A brief summary of PCR cloning is as follows: 
The primers used to amplify cDNAs had the appropriate restriction enzyme 
site on the 5’ end of the primer. PCR was performed using a reaction mixture 
containing 1µl of template DNA (50ng), 1µl of the forward primer (100ng/µl), 1µl of 
the reverse primer (100ng/µl), 1ul of dNTPs (10mM each), 1X PCR buffer, double 
distilled water and 1 µl of Taq polymerase enzyme mix. The reaction cycles carried 
 Chapter 2 Materials and Methods 
 42 
out using a thermocycler (Perkin Elmer) and the manufacturers protocol. The DNA 
bands required were isolated on standard agarose gels. The product was recovered by 
excision of the band from the agarose gel using Qiaquick gel extraction kit according 
to the manufacturers protocol (Qiagen). The PCR product and the vector were 
separately digested with required enzymes over night at 37degrees. The vector was 
treated with Calf intestinal phosphatase (CIP) and recovered after CIP treatment using 
the Qiaquick gel extraction kit. This was followed by ligation and transformation. 
Ligation of the insert with vector was carried out with T4 DNA ligase (Promega), 
overnight at 16oC. Transformation of the ligation mixture was then done using heat 
shock transformation (only for ligations) or electroporation transformation (for all 
other plasmids) method. 
2.1.2.1 Details of specific constructs 
To generate all the Duf mutant constructs site directed mutagenesis was used 
using nested PCR and primers that contained base changes to generate the mutations. 
To generate the Duf 4-phos-flag mutant, phosphorylation sites were mutated in 
succession. pAc5.1C Loner was generated using genomic DNA from UAS-Loner 
flies. pUAST-Mute-S was generated by subcloning the cDNA clone RE27864 
(Drosophila Genomic Resource Centre) into the EcoR1 site of pUAST. PUAST-
Mute-L was generated using a 2.7kb fragment of RE27864 from the Sma1-EcoR1 
sites and joining this to a 3.7kb fragment amplified from WT genomic DNA. This 
5.4kb fragment was inserted into the Not1-Xho1 sites of pUAST. pUAST-Mute∆C was 
generated by introducing a stop codon at position 5038 of the coding sequence. 
pUAST-Mute∆C-Atro was obtained while screening for clones of Mute-L. This clone 
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was selected and named such since it had a stop codon at position 2356 of the coding 
sequence. 
List of DNA constructs used in this study 
DNA construct Source Reference 
pAc5.1A-Dufflag S.D. Menon (Menon et al., 2005) 
pAc5.1C-HA-Rols S.D. Menon (Menon et al., 2005) 
pAc5.1C-Loner-V5 S. Bulchand PLoS in press 
pAc5.1C-and pUAST-
DufTM DE-Cadh-flag 
S. Bulchand PLoS in press 
pAc5.1C- and pUAST-
DufTM Sema1a-flag 
S. Bulchand PLoS in press 
pAc5.1C- and pUAST-
DufPDZ-flag 
S. Bulchand PLoS in press 
pAc5.1C- and pUAST-
Duf 4 phos-flag 
S. Bulchand PLoS in press 
pAc5.1C- and pUAST-
Duf ∆CT1-flag 
S. Bulchand PLoS in press 
pAc5.1C- and pUAST-
Duf ∆CT2-flag 
S. Bulchand PLoS in press 
pAc5.1C- and pUAST-
Duf ∆CT3-flag 
S. Bulchand PLoS in press 
pAc5.1C- and pUAST-
Duf PADVI-flag 
S. Bulchand PLoS in press 
pUAST-Duf ∆CT4-flag S. Bulchand PLoS in press 
pUAST-Duf ∆CT5-flag S. Bulchand PLoS in press 
UAS-Mute-L S. Bulchand manuscript under revision 
UAS-Mute-S S. Bulchand manuscript under revision 
UAS-Mute ∆C S. Bulchand manuscript under revision 
UAS-Mute ∆C-Atro S. Bulchand manuscript under revision 
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2.1.3 Strains and growth conditions 
The E. coli strain DH5αα (GIBCO BRL) was used throughout this study for 
all cloning procedures. BL21 strain was used to express proteins for antigen 
production. E. coli cells were either cultured in liquid Luria Bertani medium (LB-1% 
bacto-tryptone, 0.5% bacto-yeast extract. 1% NaCl pH 7.0) or maintained on LB agar 
plates (LB containing 1.5% bacto-agar) at 37oC. When recombinant plasmid-
containing cells were cultured, the media was supplemented with Ampicillin or 
Kanamycin as required, at 100ug/ml. 
2.1.4 Transformation of E. coli cells 
2.1.4.1 Heat shock transformation of E. coli 
The competent cells were thawed on ice, and 10-20 µl of the ligation reaction 
mix was added and the cells kept on ice for 15 minutes. The cells were heat shocked 
at 42 oC for 60 seconds in a water bath and chilled on ice for 1 minute. The cells were 
then recovered in 1ml of SOC media lacking antibiotic at 37oC for 1 hour.  They were 
then briefly spun and resuspended in 100ul of LB. The cells were then spread on LB 
agar plate containing the appropriate antibiotic. 
2.1.4.2  Transformation of E-coli by electroporation 
The electrocompetent cells were allowed to thaw on ice. 1-2µl of ligation 
reaction was added to the cells and mixed gently. The mixture was then transferred to 
a cold, 0.2 cm electroporation cuvette. The Gene Pulser Apparatus (Biorad) was used 
for transformation. The cells were recovered in SOC and incubated at 37°C for 1 hr, 
with shaking and plated on selective medium. 
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2.1.5 Plasmid DNA preparation 
2.1.5.1 Plasmid mini prep 
A 3ml LB culture of the appropriate plasmid containing cells was set up with 
the required antibiotic and the cells were shaken vigorously for 8-12 hours at 37°C. 
The cells were then collected in 1.5 ml Eppendorf tubes and spun at maximum speed 
(14,000 rpm) in microfuge for 30 sec. Plasmid minipreps were carried out using the 
QIAprep Miniprep kit from Qiagen according to manufacturer’s protocol.  
2.1.5.2 Plasmid maxi prep  
Plasmid midi/maxipreps of bacterial cultures (500 ml) were performed with 
the Nucleobond AX Plasmid Maxi Kit (Macherey Nagel) as per the manufacturers 
protocol.   
2.1.6 Total RNA extraction 
100 embryos were collected of each genotype. Homozygous mutants were 
selected on the basis of absence of the GFP balancer. Embryos were homogenized and 
total RNA was extracted using the Trizol method and the RNeasy mini kit (Qiagen). 
Total RNA was treated with DNaseI to remove genomic DNA contamination 
followed by heat inactivation at 75 oC for 15 min. RNA was quantified using a 
nanodrop. 
2.1.7 Quantitative RT-PCR 
0.5ug of total RNA was used for cDNA generation. First strand cDNA was 
synthesized using Oligo-dT and SuperScript RT-III (Invitrogen). These samples were 
treated with RNase-H and then used for the qPCR. cDNA samples were diluted 20 
fold for the qPCR. SYBR Green PCR master mix, quantitative PCR machine and 
software from Applied Biosystems was used. 
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2.1.8 RNA probe generation 
All RNA work was carried out using DEPC treated water. Primers were 
designed against the N and C terminal regions of Mute-L. the reverse primer had an 
additional T7 promoter sequence at the 5’end. These regions of Mute (~500bp) were 
amplified using standard PCR methods and YW genomic DNA as template. The 
amplicon was excised and purified from the agarose gel and an in vitro transcription 
reaction was set up using digoxigenin (DIG) labeled UTP’s as per the manufacturers 
protocol (Roche). The mix was incubated at 37 oC for 4 hours following which 1ul of 
DNaseI was added and incubated for another 15 min. The RNA was precipitated 
using 4M LiCl and 100% ethanol at -80 oC overnight. The RNA was spun down at 4 
oC and washed with 70% ethanol and re spun again. The pellet was air dried and re 
suspended in Rnase free water. The RNA was quantified using a nanodrop.  
List of primers used in this study: 
All primer sequences are listed starting with the 5’end. F=Forward, 
R=Reverse. All sequences start from the 5’ end. Mutations and Flag-epitope 
sequences are underlined. Overhangs and restriction enzyme sites are in lowercase. 
All primers between 30 and 50 bases were TOP purified and those above 50 bases 
were PAGE purified. T7 promoter is indicated in bold. North=primers for generation 
of RNA probe for northern blot. 
Primer name Primer sequence 
Duf-F aaaaaagaattcGTATGGCGGTGACTC 





Duf-Tyr 638-F TATGATGTGGAAGCCTCGGAGGCGGGC 
Duf-Tyr 638-R CGCCTCCGAGGCTTCCACATCATAGG 
Duf-Ser 680-F GATGAGCGCTTTGCGGGCGATTTCGG 
Duf-Ser 680-R ACCGAAATCGCCCGCAAAGCGCTCATCG 
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Duf-Tyr 810-F GCCATCGCTGGTAATCCCTATTTAAGGACGAACTCC 
Duf-Tyr 810-R TAAATAGGGATTACCAGCGATGGCGCTAAAGCG 
Duf-Tyr 814-F GCCATCTATGGTAATCCCGCTTTAAGGACGACGAACTCC 
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2.2 Biochemistry 
Frequently used buffers and solutions 
SDS-PAGE buffer 30.2g Tris, 188g glycine, 50ml 20% 
SDS, distilled water to 1000ml 
SDS-PAGE-resolving gel Required amounts of 30% acrylamide 
mix and deionised water, ¼ vol 1.5M 
Tris(pH8.8), 0.01 vol 10% SDS, 0.01 vol 
10% ammonium persulphate (APS), 
0.0008 vol TEMED 
Stacking gel 0.68 vol deionised water, 0.17 vol 30% 
acrylamide, 0.125 vol 1.0M Tris (pH 
6.8), 0.01 vol 10% SDS, 0.01 vol 10% 
APS, 0.001 vol TEMED 
Western blot transfer buffer 3g Tris, 14.4g glycine, 200ml methanol, 
distilled water to 1000ml 
Blocking solution PBS, 3% skimmed milk powder, 0.05% 
Triton X-100 
 
2.2.1 Extraction of proteins from embryos 
200 embryos each were homogenized in lysis buffer (0.25M sucrose, 60mM 
KCl, 15mM NaCl, 5mM MgCl2, 1mM CaCl2, 15mM Pipes pH 6.8, 0.8% Triton x-
100, 0.1mM Pefabloc and protease inhibitor cocktail (Roche). All procedures were 
carried out at 4oC. Samples were mixed with equal volume of 2X Laemmli Buffer and 
boiled for 5 min, spun at 13,000rpm for 1min. the supernatant was stored as –80 oC 
2.2.2 PAGE and Western blotting of protein samples 
5-20µg of protein extracts were mixed with equal volume of 2X Laemmli 
buffer and boiled for 5 minutes, after which the sample was loaded on the SDS gel. 6-
15% SDS PAGE gels were used depending on the molecular weight of the protein 
being studied.  Electrophoresis was carried out in a minigel apparatus (Biorad) at 80 
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V for 20 minutes and subsequently at 120 V for 2-2.5 hours. Proteins were transferred 
onto a PVDF membrane (Immobilon-PSQ, Millipore) at 90V for 1.5 hours at 4oC.  
2.2.3 Immunological detection of proteins 
Membranes were blocked in 5% non fat milk for 1 hour at room temperature 
(RT). Membranes were washed with PBTw (1XPBS, 0.1 % Tween) for 10 min X 4. 
and probed with anti mouse HRP, 1:10000 (Roche) for 1 hour at RT. Membranes 
were washed with PBTw (1XPBS, X % Tween) and proteins were detected by 
chemiluminescence using Luminol and Coumaric acid (Sigma) and Amersham 
HyperfilmECL.  
2.2.4 Co-Immunoprecipitations 
S2 cells were transfected and harvested 44 hours post transfection by 
centrifugation at 1000 rpm and washed twice in 1X PBS. Cells were re suspended in 
800ul ice cold immunoprecipitation (IP) buffer (50mM Tris pH 7.4, 150mM Sodium 
Chloride, 2mM EDTA, 1% Triton-X 100, 0.5% NP40 and EDTA free complete 
protease inhibitor tablets (Roche) and passed 6 times through a 261/2G needle to lyse 
the cells. Cells were centrifuged at 14,000 rpm in a refrigerated centrifuge and the 
supernatant was collected. 50ul of 2X Laemmli buffer was added to 50ul of the 
supernatant and boiled for 5 minutes. This was used as the input. To the rest of the 
supernatant 60ul of anti-Flag M2 agarose (Sigma) for the Duf-Loner IP and 100 ul of 
anti-HA affinity matrix (Roche) for the Duf-Rols IP was added. These were left 
overnight at 4 degrees on a roller. The mixture was spun down at 4oC for 1min at 
2000 rpm and washed in cold IP buffer. This was repeated four times. After the final 
centrifugation equal volume of 2X Laemmli buffer was added and the sample boiled 
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for 5 min. These samples were then subjected to standard western blotting procedures 
as described above. 
2.2.5 Acid extraction of Histones 
200 embryos each were homogenized in lysis buffer (0.25M sucrose, 60mM 
KCl, 15mM NaCl, 5mM MgCl2, 1mM CaCl2, 15mM Pipes pH 6.8, 0.8% Triton x-
100, 0.1mM Pefabloc and protease inhibitor cocktail (Roche). All procedures were 
carried out at 4oC. Homogenate was spun at 10,000g for 20min. 0.5ml of 0.4M 
H2SO4 was used to resuspend the pellet and incubated on ice for 1 hour to acid 
extract the histones. Samples were spun at 12,000g for 5 min. Acid treatment was 
repeated on the pellet. Supernatants were pooled. 12X volume of acetone was added 
to the supenate and left at –20oC overnight to precipitate proteins. Samples were spun 
at 10,000g for 15 min. The Pellet was air dried and resuspended in 4M urea. Total 
protein was quantified. 2X Laemmli buffer was added and boiled for 5 min. 5ug 
protein was loaded per well. 
2.2.6 Protein expression 
Antigenic regions for anti-Mute-L was amino acid 3-164 and for anti-Mute-LS 
amino acid 1093-1291 of the Mute protein sequence (FlyBase). These regions were 
PCR amplified and cloned into the pET28-His tagged vector (Novagen).These 
plasmids were transformed into BL21 cells. Following a trial induction of protein 
expression using 3 ml of culture, a large scale induction was carried out as follows. A 
bacterial culture in LB was inoculated overnight at 37 oC. the following day this 
culture was diluted 100 fold and kept in a shaker at 37 oC until the OD600 was between 
0.6 and 0.8. 1ml of culture was removed as the un-induced control. To the rest IPTG 
was added to a final concentration of 1mM. This was incubated at 37 oC for 4 hours 
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while shaking and then spun down at 4 oC at 7000rpm. The protein was purified from 
the pellet using the Qia expressionist system. The pellet was re suspended in lysis 
buffer. Lysozyme was added to a final concentration of 1mg/ml and left on ice for 30 
min. the lysate was then sonicated followed by incubation with Ni-NTA agarose 
beads (Qiagen) at 4 oC for 2 hours while rolling. The lysate was then poured through a 
pre-packed column. Following several washes. The protein was eluted using the 
appropriate buffer and 1lm fractions of the eluate were collected. These fractions were 
run on an SDS-PAGE gel to check for protein induction. The best fractions were 
pooled and dialysed in 1X PBS to remove all traces of urea, using dialysis cassettes 
(Pierce). This process was carried out for 2 days with 6 hourly changes in PBS. 
Following quantification, the required amount of protein was mixed with Freunds 
adjuvant (Sigma) for animal injection. 
2.2.7 Antibody generation 
The antigen as above was mixed with Freunds complete adjuvant and injected 
into animals as follows. 250ug/animal was used for mice and guinea pigs and 500ug/ 
animal was used for rats and rabbits. Subsequent injections were performed using 
Freunds incomplete adjuvant. The animals were injected every fortnight. After the 6th 
injection a trial bleed was done extracting about 100ul of blood from each animal. 
The sample was spun down at 13K rpm to separate the blood cells from the serum. 
Once tested, a final booster shot was given and the animal were bled 10 days after. 
The final bleed was done using the cardiac puncture method for rats, rabbits and 
guinea pigs while the eyeball nerve cutting method was done for mice. All animals 
were treated with anaesthetic and sacrificed as per the animal veterinary authority 
protocol. The collected blood was kept at 37 oC fr 2 hours to ensure clotting andthen 
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spun down to separate the serum. This serum contained the required antibody that was 
tested on YW and mutant embryos for verification. 
2.2.8 Northern blotting 
All reagents and apparatus were cleaned with DEPC treated water before use. 
The entire procedure was carried out as per manufacturers instructions (Roche). 
Briefly, RNA samples were separated on a 2% formaldehyde-MOPS gel. The RNA 
from the gel was transferred to a positively charged nylon membrane (Hbond) using 
the capillary method by making a blot “sandwhich”. The RNA was allowed to transfer 
over night at RT. The RNA was then fixed to the blot by UV crosslinking in a UV 
Stratalinker. The blot was then placed in a glass tube with DIG Easy Hyb granules 
(Roche) and allowed to roll for 1 hr at 55 degrees. 100ng probe/ml hybridisation 
buffer was added to the blot after denaturation at 68 oC. Low and high stringency 
washes were performed. Detection was carried out using CDP-Star (Roche) and 
Amersham HyperfilmECL.  
2.3 Immunofluorescence and microscopy 
Frequently used buffers and reagents for immunohistochemistry 
PBS (phosphate buffered saline) 130mM NaCl, 7mM Na2HPO4, 3mM 
NaH2PO4, pH 7.5 
PBT (PBS with Tween-20) PBS, 0.1% Triton X-100 
4% PFA (Paraformaldehyde) For 10ml, mix 2.5ml 16% PFA with 1ml 
ml 1M HEPES pH 7.4. Prepare fresh 
fixative each time. 
Block- 3% BSA-PBT (bovine serum 
albumin in PBT) 
3g of BSA (Sigma) in 100ml PBT 
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2.3.1 Fixing drosohila embryos 
Embryos were collected at 25oC and washed in PBT (1X PBS and 0.1% Triton 
X-100), dechorionated in 50% bleach, rinsed in PBT, fixed in 1:1 heptane : 4% 
methanol free paraformaldehyde (4%PFA with 0.1M Hepes pH 7.4) for 15 min while 
shaking, devitellinated in 1:1 heptane : methanol for 1 min and stored in 100% 
ethanol at -20oC. 
2.3.2 Fixing Drosophila embryos for staining with anti-Mute 
Embryos were collected as above, and fixed in 4%PFA: heptane for 45 min. 
embryos were removed from the interface and placed on 2 sided sticky tape immersed 
in 1X PBS. The vitelline membrane was removed manually with 26G needles. 
Embryos were transferred into 3% BSA-PBT containing sodium azide to prevent 
growth of fungus/bacteria and stored at 4°C for upto one week. 
2.3.3 Fixing larval salivary glands 
Third instar larval salivary glands were dissected in 1X PBS. They were fixed 
in 4% PFA for 20 min. Following this, they were washed several times in PBTand 
processed for immunohistochemistry.  
2.3.4 Antibody staining of fixed tissues 
For immunostaining, embryos were rehydrated in PBT and blocked in 3% 
BSA-PBT. Samples were incubated with primary antibodies overnight at 4 oC. After 
4-5 washes in PBT, samples were incubates with secondary antibodies conjugated to 
Cy3 (Jackson ImmunoResearch Laboratories, Inc) or Alexa Fluor 488 (Molecular 
Probes). Samples were mounted in Vectashield (Jackson ImmunoResearch 
Laboratories, Inc) and analysed under a confocal microscope (Zeiss LSM 5 Exciter). 
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2.3.5 Transfecting, fixing and staining S2 cells 
2 X 106 number of S2 and Hela cells were seeded onto polylysine coated 
coverslips (Iwaki) in a 6 well dish for 24 hours. For S2 cell transfections, 0.5 ug each 
of Flag epitope tagged wild type Duf and the Duf mutant constructs together with 0.5 
ug of either HA-Rols or Loner-V5 was co transfected into these cells using the Qiagen 
effectene transfection reagent. DNA to effectene ratio was maintained at 1:20. 44 
hours post transfection cells were washed in 1X PBS. Cells  (S2 and Hela) were fixed 
in 3%PFA for 30 min at room temperature (RT), washed thrice in 1X PBS followed 
by incubation in PBT for 15 min to permeabilise the cells. Primary antibodies were 
applied for 1hour at RT. Cells were washed 5 times in PBT. Secondary antibodies 
were conjugated to Cy3 (Jackson ImmunoResearch Laboratories, Inc) or Alexa Fluor 
488 (Molecular probes). Nuclei were labeled with Hoechst 33258 (Invitrogen). 
Coverslips with cells were mounted in Vectashield (Jackson ImmunoResearch 
Laboratories, Inc). Images were obtained under a confocal microscope (Zeiss LSM 5 
Exciter). 
2.3.6 Antibodies used in this study 
Antibody Dilution Source 
mouse anti-MHC 1:50 Daniel Kiehart 
rabbit anti-Eve 1:5000 (Frasch et al., 1987) 
mouse anti-BGal 1:250 Promega 
rabbit anti-BGal 1:2000 Cappel 
Chicken anti-GFP 1:3000 Abcam 
rabbit anti-Dmef2 1:1000 Bruce Paterson/Hanh Nguyen 
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rabbit anti-How 1:1000 Talila Volk 
anti-cleaved Caspase 3 1:500 Cell Signaling Technology 
guinea pig anti-DTitin 1:1000 This lab 
mouse anti-Lamin 1:300 DSHB 
mouse anti-HP1 1:50 (IF)  1:200 (Western) DSHB 
mouse anti-Dlg 1:200 DSHB 
rabbit anti-Mute-L 1:1500 This lab, manuscript submitted 
guinea pig anti-Mute-LS 1:1500 This lab, manuscript submitted 
rabbit anti-FLASH 1:500 Santa Cruz Biotechnology, Inc. 
mouse anti-Tubulin 1:3000 Sigma 
rabbit anti-H3 1:800 Santa Cruz Biotechnology, Inc. 
rabbit anti-H4 1:1000 Abcam 
rabbit anti-dimet H3K9 1:500 Millipore 
mouse anti-V5 1:200 Invitrogen 
rabbit anti-flag 1:400 Affinity BioReagents 
guinea pig anti-D-Titin 1:1000 This Lab 
rabbit anti-dLsm10 1:2000 Joseph Gall 
rabbit anti-dLsm11 1:2000 Joseph Gall 
rabbit anti-H3 1:800 Santa Cruz Biotechnology, Inc. 
rabbit anti-H4 1:1000 1:1000 Abcam 
rabbit anti-dimet H3K9 1:500 Millipore 
rabbit anti-Ac H3K9 1:1000 Millipore 
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rabbit anti-trimet H3K9 1:1000 Abcam 
rabbit anti-H2aV 1:1000 Robert Glaser 
anti rabbit-HRP 1:10000 Roche 
anti mouse-HRP 1:10000 Roche 
 
2.3.7 Confocal analysis and image processing 
Stained and mounted tissue samples in vectashield were analysed with the 
Zeiss LSM 5 Exciter confocal microscope. All digital images were processed using 
Adobe Photoshop. 
2.4 Live Imaging of embryonic muscles 
The MHC-Tau-GFP line was used to image mute1281 embryos after 
deposition of the cuticle. The protocol used is as described in (Dutta et al., 2002). 
Briefly, embryos were collected, manually dechorionated, immersed in halocarbon oil 
and mounted in an oxygen permeable chamber. A single embryo was imaged every 9 
min for a period of 10 hours. For each timepoint a stack of Z sections was taken and 
reconstructed into a 3D image. A Zeiss Axioplan microscope was used. 
2.5 Fly genetics 
2.5.1 Nomenclature used in this thesis 
All gene names, genomic loci and mRNAs are in small case, italics. All 
protein names are in small regular case with capital first alphabet. All mutants are 
small case, italics and are mentioned either as mutants or have a superscript for allele 
identity. Genes on the same chromosome are separated by “,” and those on different 
chromosomes by, “;”. 
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Fly stocks used in this study 
Fly stock Source Reference 
duf,rst Df(1)w67k30  Mar Ruiz-Gomez (Ruiz-Gomez et al., 2000) 
loner T1032  Elizabeth Chen (Chen et al., 2003) 
rols Df(3L)BK9  Sree Devi Menon (Menon and Chia, 2001) 
D-wip D30  Eyal Schejter (Massarwa et al., 2007) 
mbc 11.2  Susan Abmayr (Erickson et al., 1997) 
Dmef2 22-21  Hanh T. Nguyen (Bour et al., 1995) 
blow2  Steven.K. Doberstein (Doberstein et al., 1997) 
UAS-duf Mar Ruiz-Gomez (Ruiz-Gomez et al., 2000) 
UAS-duf flag Sree Devi Menon (Menon et al., 2005) 
UAS-loner Elizabeth Chen (Chen et al., 2003) 
UAS-dufTM DE-Cadh-flag S. Bulchand PLoS ONE, in press 
UAS -dufTM Sema1a-flag S. Bulchand PLoS ONE, in press 
UAS -dufPDZ-flag S. Bulchand PLoS ONE, in press 
UAS -duf 4 phos-flag S. Bulchand PLoS ONE, in press 
UAS -duf 2 phos-flag S. Bulchand PLoS ONE, in press 
UAS -duf ∆CT1-flag S. Bulchand PLoS ONE, in press 
UAS -duf ∆CT2-flag S. Bulchand PLoS ONE, in press 
UAS -duf ∆CT3-flag S. Bulchand PLoS ONE, in press 
UAS -duf ∆CT4-flag S. Bulchand PLoS ONE, in press 
UAS -duf ∆CT5-flag S. Bulchand PLoS ONE, in press 
UAS -duf PADVI-flag S. Bulchand PLoS ONE, in press 
rols Df(3L)BK9, loner T1032 S. Bulchand PLoS ONE, in press 
blow2; loner T1032 S. Bulchand PLoS ONE, in press 
blow2; rols Df(3L)BK9 S. Bulchand PLoS ONE, in press 
D-wip D30; loner T1032 S. Bulchand PLoS ONE, in press 
D-wip D30; rols Df(3L)BK9 S. Bulchand PLoS ONE, in press 
24B-GAL4 Bloomington stock centre  
rp298-GAL4 Mar Ruiz-Gomez  
mute 1281 S. Bulchand manuscript under revision 
UAS-mute-L S. Bulchand manuscript under revision 
UAS-mute-S S. Bulchand manuscript under revision 
UAS-mute ∆C S. Bulchand manuscript under revision 
UAS-mute ∆C-Atro S. Bulchand manuscript under revision 
Df(2R)Exel 6065 Bloomington stock centre manuscript under revision 
MHC-Tau-GFP E. Chen and Eric Olson  
P{GawB} NP1160 Bloomington stock centre  
rp298-lacZ Akinao Nose (Nose et al., 1998) 
Df H99 (removes grim, 
rpr, hid) 
Bloomington stock centre 
 
lsm11c02047 Robert Duronio (Godfrey et al., 2009) 
U720 Robert Duronio (Godfrey et al., 2006) 
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UAS-Kettin-GFP Mar Ruiz-Gomez  
slbp15 Robert Duronio (Sullivan et al., 2001) 
 
2.5.2 EMS mutagenesis 
All procedures were carried out in a biohazard hood. EMS and any apparatus 
that was in contact with EMS was denatured with NaOH in thioglycolic acid. Freshly 
hatched adult male flies were placed in vials with fly food for and aged for ~3 days. 
The flies were then starved for a day, in an empty bottle containing moist filter paper. 
These filter papers were replaced with dry ones and ethyl methane suphonate at 
30mM prepared in 1% sucrose, was layered on this dry filter paper. ~100 flies per 
bottle were allowed to feed on the mutagen for 24 hours. The flies were removed form 
the treatment bottles and allowed to feed on normal food for another 24 hours. About 
20 mutagenised males were crossed with Gla/Cy-Act-GFP females for ~3 days. The 
males were then removed and females were transferred to fresh food every 2 days for 
upto 10 days. From the progeny single males were crossed to the same balancer stock. 
Their progeny were maintained as stable lines and initially screened for lethality.  
~2500 embryonic lethal lines were screened for muscle defects ranging from 
myoblast fusion to degenerating muscles.  
2.5.3 Staging embryos and nuclear counts 
Nuclei were counted using 40× magnification on a Zeiss Axiophot microscope 
using standard fluorescence settings and and the Zeiss LSM5 confocal microscope for 
imaging. For each muscle/mutant condition analyzed, 40 hemisegments (abdominal 
hemisegments 2–5) at stage 16 was counted (10 embryos total). Embyo collections 
were at 25°C. Graphing of data and statistical analysis was performed with Microsoft 
Excel. 
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2.5.4 Germ line transformation 
Transgenic flies were generated as described previously (Spradling, 1986). 
Constructs were cloned into the pUAST vector and expressed using gal4-UAS (Brand 
and Perrimon, 1993). The transgenic services of Genetic Services and Best Gene Inc. 
were used. Results are representative of two independent insertions for each 
transgene. Rescues were performed using single copies of the UAS transgene and 
24B-Gal4 or rp298-Gal4 in duf,rst mutant embryos or mute1281/Df embryos. 
2.5.5 Germ line clones 
Female virgin flies with mutations that were recombined with the FRT42B 
element were crossed with hs-FLP; ovoD1, FRT42B males. The flies were allowed to 
lay eggs for 24 hrs at 25°C. A first heat shock was given at 72 hours of development 
for 2 hrs at 37°C. A similar second heat shock was given at 96 hours of development. 
Virgin females were crossed to deficiency males to analyse the progeny. 
2.5.6 Single fly PCR 
A single fly was placed in a 0.5 ml tube and homogenised for 5 - 10 seconds 
with a pipette tip containing 50µl of buffer (10 mM Tris-Cl pH 8.2, 1 mM EDTA, 25 
mM NaCl, and 200 µg/ml Proteinase K, with the enzyme diluted fresh from a frozen 
stock each day) without expelling any liquid. The remaining buffer was then expelled 
into the tube. This was then incubated at 25-37oC for 20-30 minutes. This incubation 
was then followed by heating the tube to 95oC for 1-2 minutes, which inactivates the 
Proteinase K. 0.5µl of the DNA from a single fly was then used for one PCR reaction. 
Loner cDNA was obtained in this manner. 
 Chapter 2 Materials and Methods 
 61 
2.5.7 Genomic DNA extraction from embryos 
100ul volume of yw (WT) and mute1281 embryos were collected and were 
homogenised in 300ul lysis buffer (100mM Tris pH 5.5, 10mM EDTA, 350mM 
NaCl, 2% SDS, 7M Urea). Equal volume of phenol: chloroform: isoamyl alcohol, 25: 
24: 1 was added and the tube was inverted several times. The mix was spun at 13000 
rpm for 15 min at 4°C. this step was repeated with the aqueous supernatant. The 
aqueous layer was collected and 2.5X volume of 100% Ethanol was added to it. The 
mix was spun for 5 min as above. To the pellet 1ml of 70% Ethanol was added and 
spun again. The pellet was air dried and resuspended in Tris-EDTA buffer. This was 
used for sequencing of candidate genes including mute. 
2.6 Cell culture 
Drosophila Schneider cells (S2 or SL2) were grown at 25 oC in the absence of 
CO2. Shields and Sang M3 Insect Medium (Sigma) was used to passage the cells 
every 4 days. Hela cells were maintained at 37 with 5%CO2. They were passaged 
every 4 days in DMEM medium and 1X Trypsin-EDTA to dislodge the cells. Both 
media were supplemented with 10% non heat inactivated FBS. 
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3 Results: The intracellular domain of Dumbfounded affects 
myoblast fusion efficiency and interacts with Rolling Pebbles and 
Loner 
3.1 Background 
Cell-cell fusion is crucial for the development of multicellular organisms and 
is required for processes as diverse as fertilisation, the formation of bone and placenta 
and myogenesis (Blumenthal et al., 2003; Chen et al., 2007). Aggregation and fusion 
of mononucleated myoblasts, that lead to the formation of multinucleated muscle 
fibres, is an essential early step in skeletal muscle differentiation. Most studies of 
myoblast fusion have utilised mammalian culture systems (Knudsen, 1992). Together 
with recent in vivo studies in mouse knockout models and zebrafish, several classes of 
proteins have been implicated in myoblast fusion, including adhesion molecules, 
metalloproteases, protein kinases and phospholipases (Abmayr et al., 2003; Horsley 
and Pavlath, 2004; Knudsen, 1992; Srinivas et al., 2007).  
Unlike mammalian skeletal muscles that take weeks to generate, the simpler 
somatic musculature of Drosophila develops within hours of egg laying and hence 
offers a good in vivo system to study this process. Cellular events of recognition, 
adhesion, alignment and membrane fusion and also some genes involved in 
Drosophila myoblast fusion are conserved in vertebrates (Abmayr et al., 2003; 
Baylies and Michelson, 2001). 
In Drosophila, control of myoblast fusion and muscle differentiation is exerted 
in two ways, first by the segregation of FCs at specific locations in the mesoderm 
(Bate, 1990) and second by the asymmetry of the fusion process in that FC and FCMs 
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can only fuse with each other and not with themselves (Baylies et al., 1998). Initially 
an FC fuses with one or two FCMs to form bi/trinucleated muscle precursors. 
Additional rounds of fusion between these precursors and more FCMs result in the 
formation of multinucleated myotubes (Bate, 1990). 
Genetic and molecular studies have yielded significant insights into the 
mechanisms underlying myoblast fusion. Some gene products are involved in 
attraction and adhesion of FCs and FCMs and in initiating the fusion process while 
others are required for downstream intracellular events that eventually lead to changes 
in cytoskeletal organisation (Richardson et al., 2008c).  
The first step is the recognition between FC and FCM. This is mediated by 
cell type specific immunoglobulin superfamily proteins, Dumbfounded (Duf) and 
Roughest (Rst), that function redundantly in the FC while Sticks and stones (Sns) 
functions in the FCMs. Duf and Rst interact with Sns and appear to be the primary 
mediators of myoblast adhesion (Bour et al., 2000; Ruiz-Gomez et al., 2000; 
Strunkelnberg et al., 2001). In the duf,rst mutant, attraction, adhesion and fusion is 
completely blocked although the founders elongate to span the territory they would 
have occupied as syncytial fibres in wild type conditions (Ruiz-Gomez et al., 2000). 
Duf is a 959 amino acid protein that shows an overall similarity of 45% with Rst. Duf 
has a highly conserved extracellular domain comprising five immunoglobulin repeats, 
a transmembrane domain and a less conserved intracellular domain (Strunkelnberg et 
al., 2001). It has been shown that in the absence of the extracellular domain FCMs are 
not attracted towards the FC and fusion fails. In the absence of the intracellular 
domain fusion is not sustained beyond the first phase, stalling at the bi/tri nucleate 
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precursor stage. This suggests that Duf possibly interacts with downstream molecules 
that are required to sustain the fusion process (Menon et al., 2005) (Figure 3.1). 
Rolling pebbles (Rols), an FC specific multidomain scaffold protein and 
Loner, an Arf-GEF, have been shown to translocate to sites of cell-cell contact in a 
Duf dependent manner, both in S2 cells and in embryos (Chen et al., 2003; Menon et 
al., 2005). The intracellular domain of Duf has been implicated in the translocation of 
Rols (Menon et al., 2005). Mutations in both rols and loner block fusion at the 
bi/trinucleate precursor stage though minimal fusion occurs in loner mutants (Beckett 
and Baylies, 2007; Chen and Olson, 2001; Chen et al., 2003; Menon and Chia, 2001). 
Rols and Loner are thought to function in a cascade of events that link Duf with the 
reorganisation of the cytoskeleton. Rols has been shown to recruit a muscle 
sarcomeric protein D-Titin to points of membrane contact during myoblast fusion 
(Menon and Chia, 2001) and to associate with Mbc, the fly homologue of DOCK180 
that has been implicated in signalling to the cytoskeleton (Erickson et al., 1997; Nolan 
et al., 1998; Rushton et al., 1995). Both Rols and Loner pathways are thought to 
converge onto the small G protein and cytoskeletal regulator Rac (Chen et al., 2003) . 
Interestingly Drac1 and Drac2 have been shown to play essential roles in myoblast 
fusion (Hakeda-Suzuki et al., 2002). Rols has also been implicated in replenishing 
Duf at the surface of the precursor thereby sustaining fusion (Menon et al., 2005). 
While it has been shown that Duf interacts with Rols (Chen and Olson, 2001) no such 
interaction has been shown for Loner.  















Figure 3.1 Known functions of Duf 
The extracellular domain of Duf functions as an attractant while the intracellular 
domain functions in the translocation of Rols and Loner to sites of cell contact and is 
essential for the sustenance of fusion 
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Given the importance of Duf during myogenesis, I asked if the intracellular 
domain of Duf contained any specific sites or regions that could reveal how the 
extracellular signals are transduced intracellularly. Duf and Rst share significant 
homology in their extracellular and transmembrane regions. Stretches of high 
conservation reside primarily in the region of the immunoglobulin domains. The 
intracellular domain of Duf is considerably longer than that of Rst and displays only 
low overall homology of 15% with that of Rst. (Ruiz-Gomez et al., 2000; 
Strunkelnberg et al., 2001). Despite this, their intracellular domains show the presence 
of well conserved putative signalling motifs namely, 4 putative phosphorylation sites 
(3 Tyrosines and 1 Serine) two of which lie in a putative autophosphorylation domain, 
a PADVI motif and a C terminal PDZ binding domain (Strunkelnberg et al., 2001) 
(Figure 3.2A). Phosphorylation of Tyrosine residues in the intracellular domain of Sns 
has been shown to play an important role in myoblast fusion (Kocherlakota et al., 
2008). Also, the PDZ binding domain of Rst has been shown to play an important role 
in Drosophila eye development (Vishnu et al., 2006). On the other hand the function 
of the PADVI motif is unknown. Transmembrane domains have been shown to be 
critical for membrane fusion and lipid bilayer mixing (Ungermann and Langosch, 
2005). These sites were mutated individually in addition to larger intracellular 
truncations in order to uncover important functional domains of Duf (Figure 3.2B). 
The function of these regions was addressed by assessing their ability to translocate 
Rols and Loner to sites of cell-cell contact in S2 cells and their ability to rescue the 
fusion defect in duf;rst mutant embryos.  
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In this chapter I show that the intracellular domain of Duf between amino 
acids 687 and 830 is important for the translocation of both Rols and Loner. This 
region is also important for interaction with Rols and Loner and for efficient fusion. 
Putative signalling motifs analysed suggest that they are additive in function. This 
implies that Duf might have multiple downstream functions and interactors that play a 
role in different aspects of fusion, finally leading to the formation of a mature muscle. 
3.2 Results 
3.2.1 Duf intracellular domain between amino acid 687 and 830 is required for 
the translocation of Rols and Loner in S2 cells: 
In order to delineate intracellular and transmembrane regions of Duf that are 
critical for its function, putative signalling motifs and regions conserved with Rst 
were mutated using site directed mutagenesis as indicated in Figure 3.2B. Here, Duf 
function was tested by assaying for the translocation of Rols and Loner to sites of 
cell-cell contact in S2 cells. All constructs were tagged with the Flag epitope at the C 
terminus. The transmembrane domain of Duf was replaced with that of DE Cadherin 
(DE Cadh)/Shotgun (Shg) that has been shown to play an important role in cell 
adhesion during Drosophila epithelial morphogenesis (Tepass et al., 1996) (Duf TM DE-
Cadh-flag) and Semaphorin 1a (Sema-1a) that is involved in axon guidance (Yu et al., 
1998) (Duf TM Sema-1a-flag). The transmembrane domains of DE-Cadh and Sema-1a 
have stretches of similar and dissimilar amino acid sequences respectively compared 
to that of Duf as indicated below 
Duf: LLVVMGSMFCVAIILMIVMIIIVY,  DE-Cadherin: FIIAIIVCLALLLIILLAVV 
Sema 1a: TLVMAVLAGSIFSLLVGFFTGYE 
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Adjacent to the transmembrane domain is a conserved series of amino acids forming a 
PADVI domain the function of which is unknown. This was mutated to DVPAI (Duf 
PADVI-flag). Four putative phosphorylation sites namely, one Serine (Ser 680) and three 
Tyrosine (Tyr 637, 810 and 814) residues were mutated to Alanine (Ala) in a single 
construct (Duf 4phos-flag). Tyr 810 and 814 lie in a putative autophosphorylation 
domain. These were also mutated in a single construct (Duf 2phos-flag). A PDZ binding 
motif THV, at the extreme C terminus was mutated to GAG (Duf PDZ-flag). In addition, 
to test if larger regions of the intracellular domain were involved in any specific 
functions, three truncated forms of Duf were generated. These were named Duf ∆CT1-
flag
, Duf ∆CT2-flag and Duf ∆CT3-flag that lacked the intracellular region after amino acids 
830, 737 and 687 removing 35%, 60% and 75% of the intracellular domain, 
respectively. Each of these mutant constructs was analysed individually.  
Previous studies have shown that Duf dependent translocation of Rols and 
Loner can be reproduced in S2 cells that adhere to each other under homotypic 
conditions (Chen et al., 2003; Menon et al., 2005). To analyse the regions of Duf 
required for the translocation of Rols and Loner, S2 cells were co-transfected with 
plasmids that expressed Flag epitope tagged wild type Duf or Duf mutants and HA 
epitope tagged Rols (HA-Rols) or V5 epitope tagged Loner (Loner-V5). As reported 
previously (Menon et al., 2005), full length wild type Duf  (Duf flag) is enriched at the 
point of homotypic cell-cell contact and Rols and Loner translocate to these points of 
cell contact in a Duf dependent manner (Figure 3.3A and G). Similarly, the mutant 
forms of Duf,  Duf TM DE-Cadh-flag , Duf TM Sema-1a-flag , Duf PADVI-flag , Duf PDZ-flag and Duf 
∆CT1-flag are also able to translocate both Rols and Loner to sites of adhesion. To avoid 
repetition only Duf and Duf ∆CT1-flag are shown (Figure 3.3B and H). Duf ∆CT2-flag and 
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Duf 4phos-flag are also able to translocate Rols to the site of adhesion (Figure 3.3C and 
E) but translocate Loner only in ~70% of the cells analysed (Figure 3.3I and K). In the 
remaining ~30% of the cells Loner translocation to the site of adhesion is not 
detectable (compare Figure 3.3I and L). This differential ability of Duf ∆CT2-flag  and 
Duf 4phos-flag to efficiently translocate Rols but not Loner, might be reflective of 
different requirements for the translocation of Rols versus Loner. 




Figure 3.2 Duf mutant constructs.  
(A) Conserved putative signalling sites and domains between Duf and Rst. 
Transmembrane domain (red), PADVI domain (green) phosphorylation sites (purple 
and arrowheads in B) Tyr (Y) 638, Ser (S) 680, Tyr (Y) 810 and Tyr (Y) 814, PDZ 
binding domain (orange). (B) Duf transmembrane and intracellular domain depicting 
the individual mutant constructs. Asterisks indicate mutated transmembrane (DE-
Cadh/Sema-1a), PADVI and PDZ binding domains and arrowheads indicate mutated 
putative phosphorylation sites. Duf ∆CT1-flag, Duf ∆CT2-flag, Duf ∆CT3-flag, Duf ∆CT4-flag and 
Duf ∆CT5-flag are truncated forms at amino acids 830, 737, 687, 610 and 597 
respectively. All constructs were tagged with the Flag epitope (blue) at the C 
terminus. nt=not tested. 
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Figure 3.3. Region between amino acids 687 and 830 is required for translocation 
of Rols and Loner.   
S2 cells were co transfected with Flag tagged wild type and mutant Duf, detected with 
anti-Flag (red) and HA-Rols detected with anti-HA (green) (A-E) or Loner-V5 
detected with anti V5 (green) (G-L). Wild type Duf flag and Duf ∆CT1-flag translocate 
both Rols (A and B) and Loner (G and H) to points of cell contact. Duf ∆CT2-flag and 
Duf 4phos-flag translocate Rols (C and E) but Loner only 70% of the time (I and K). 30% 
of the time they are unable to translocate Loner to points of contact (compare I and 
L). Duf ∆CT3-flag is unable to translocate Rols (D) and Loner (J). Rols and Loner puncta 
do not colocalise (F). Dashed lines indicate cell outlines. Scale bar = 5um. 
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Cells co-transfected with Rols and Loner show that while both proteins are 
present as cytoplasmic foci, Loner foci are larger compared to Rols foci and the two 
do not colocalise (Figure 3.3F) as previously shown by Chen et al., (Chen et al., 
2003). Duf ∆CT3-flag fails to translocate both Rols and Loner (Figure 3.3D and J). These 
results indicate that the region between amino acid 687 and 830 of the intracellular 
region of Duf is required for the translocation of Rols and Loner to sites of homotypic 
cell adhesion. This might have implications for the function of Duf during 
myogenesis in the embryo, in that, a specific region of Duf might be required to bring 
Rols and Loner to sites of myoblast fusion. Future work will address if the same holds 
true under heterotypic conditions when Duf interacts with Sns. 
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3.2.2 Region between amino acid 687 and 830 is required for interaction of Duf 
with Rols and Loner: 
I then addressed if the ability of Duf to translocate Rols and Loner was 
indicative of its physical interaction with Rols and Loner. To test this, co-
immunoprecipitation assays were performed on S2 cells co-transfected with Flag 
epitope tagged Duf constructs and either HA-Rols or Loner-V5. Duf-Rols and Duf-
Loner complexes were pulled down and individual proteins were detected on a 
western blot. Consistent with the immunofluorescence results obtained from S2 cells, 
Duf flag, Duf ∆CT1-flag and Duf ∆CT2-flag interact with both Rols (Figure 3.4A, lanes 6, 7 
and 8) and Loner (Figure 3.4B, lanes 6, 7 and 8) while Duf ∆CT3-flag fails to interact 
with either (Figure 3.4A and B, lane 9). Thus, the breakpoints of Duf ∆CT2-flag and Duf 
∆CT3-flag
 delineate a region in the intracellular domain (between amino acids 687 and 
830) required for interaction of Duf with Rols and Loner. I conclude that the region 
required for the translocation of Rols and Loner to sites of cell adhesion, is also 
required for interaction with Rols and Loner.   
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Figure 3.4 Duf intracellular domain between amino acid 687 and 830 interacts 
with Rols and Loner.  
Co immunoprecipitations (Co-IP) were performed on S2 cells co transfected with 
wild type Duf flag, Duf ∆CT1-flag, Duf ∆CT2-flag, Duf ∆CT3-flag and HA-Rols or Loner-V5. 
(A) Rols-Duf complexes were pulled down with anti-HA and probed with anti-Flag to 
detect Duf and anti-HA to detect Rols. Input (lanes 1-4) and Co-IP (lanes 5-9). Wild 
type Duf flag, Duf ∆CT1-flag and Duf ∆CT2-flag interacts with Rols (lanes 6,7 and 8) while 
Duf ∆CT3-flag fails to interact with Rols (lane 9). Cells transfected with Duf flag alone 
and immunoprecipitated with anti-HA were used as a negative control (input lane 10, 
co-IP lane 5). (B) Loner-Duf complexes were pulled down with anti-Flag and probed 
with anti-Flag to detect Duf and anti-V5 to detect Loner. Wild type Duf flag, Duf ∆CT1-
flag
 and Duf ∆CT2-flag interacts with Loner (lanes 6,7 and 8) while Duf ∆CT3-flag fails to 
interact with Loner (lane 9). Cells transfected with Loner-V5 alone and 
immunoprecipitated with anti-Flag were used as a negative control (input lane 10, co-
IP lane 5). 
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Different intracellular regions of Duf function additively for efficient myoblast fusion: 
In order to delineate putative signalling motifs or regions critical for Duf 
function during myogenesis, Duf flag and all the mutant Duf forms listed in Figure 
3.2B were tested for their ability to rescue the duf;rst mutant phenotype. The 
efficiency of rescue was quantified by counting the number of nuclei in the large 
dorsal DA1 muscle using antibodies against the DA1 identity marker, Eve, in 40 
hemisegments (abdominal A2-A5, 10 embryos). As reported previously there is a 
complete block in myoblast attraction and fusion in the duf;rst mutant (Ruiz-Gomez 
et al., 2000; Strunkelnberg et al., 2001). Uni-nucleate FCs form mini muscles 
surrounded by several unfused FCMs with randomly oriented filopodia, indicative of 
a lack of attraction between FCs and FCMs (Figure 3.5A). The reintroduction of 
untagged full length Duf, Duf flag, Duf TM DE-Cadh-flag, Duf TM Sema-1a-flag, Duf PADVI-flag 
and Duf PDZ-flag using a muscle specific driver, 24B Gal4, restores FCM attraction and 
myoblast fusion giving rise to a wild type (WT) DA1 muscle in every hemisegment 
with average nuclei numbers of 9.50 ± 1.56, 9.78 ± 0.91, 9.96 ± 0.75, 8.43 ± 1.43 and 
8.40 ± 1.45 respectively, (Table 3.1), at stage 15 of embryonic development. To avoid 
repetition only WT and Duf flag are shown  (Figure 3.5B and G). Duf ∆CT1-flag that is 
able to translocate and interact with Rols and Loner (Figure 3.3B, H and Figure 3.4) is 
also able to successfully restore myoblast attraction and fusion up to an average 
nuclear number of 8.30 ± 1.49 (Figure 3.5 C and G) compared to the wild type DA1 
nuclear number of 9.50 ± 1.56 (Figure 3.5A and G). 
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Figure 3.5 Regions in Duf 
intracellular domain function 
additively for efficient fusion.  
(A-F) Late stage 15 DA1 muscles 
labelled with anti-MHC (red) and 
anti-Eve (green). Fusion is 
completely blocked in the duf,rst 
mutant (A). UAS transgenic 
constructs driven by 24B Gal4. 
UAS duf flag (B) and UAS duf ∆CT1-
flag (C) are able to rescue the 
duf,rst mutant. UAS duf ∆CT2-flag and UAS duf 4phos-flag rescue the duf,rst mutant only partially (D 
and F). UAS duf ∆CT3-flag is unable to rescue the duf,rst mutant beyond the initial stage of 
fusion. (G) Average nuclear number per DA1 muscle in embryos rescued with UAS duf flag 
and UAS Duf mutant constructs in comparison with wild type (WT) and the duf,rst mutant. 
(H) Distribution of DA1 nuclear numbers per hemisegment in duf,rst embryos rescued with 
Duf constructs. Scale bar =20um 
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Construct Rescues duf,rst mutant Avg. number of DA1 nuclei 
Duf flag + 9.50 ± 1.56 
Duf TM DE-Cadh-flag + 9.78 ± 0.91 
Duf TM Sema 1a-flag + 9.96 ± 0.75 
Duf PDZ-flag + 8.43 ± 1.43 
Duf PADVI-flag + 8.40 ± 1.45 
Duf 4 phos-flag ± 4.61 ± 2.58 
Duf 2 phos-flag + 8.02 ± 2.06 
Duf Tyr637-flag + 8.20 ± 1.38 
Duf Ser680-flag + 7.90 ± 1.41 
Duf Tyr810-flag + 8.25 ± 1.29 
Duf Tyr814-flag + 8.00 ± 1.36 
Duf ∆CT1-flag + 8.30 ± 1.49 
Duf ∆CT2-flag ± 4.07 ± 2.15 
Duf ∆CT3-flag - 1.93 ± 1.00 
Duf ∆CT4-flag - 1.78 ± 1.13 
Duf ∆CT5-flag - 1.39 ± 0.64 
Table 3.1 Summary of fusion rescue using Duf mutant constructs  
DA1 nuclei in 40 embryonic hemisegments (10 embryos) were counted in late stage 15 
embryos. Average number of nuclei ± standard deviation is shown. Symbols and 
abbreviations: + = rescues the duf;rst mutant comparable to WT, - = does not rescue the 
duf,rst mutant. Constructs labelled in blue text are also summarised along with S2 cell data in 
Table 3.2.  
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of DA1 nuclei 
Duf flag + + + + + 9.50 ± 1.56 
Duf 4 phos-flag + nt ± nt ± 4.61 ± 2.58 
Duf ∆CT1-flag + + + + + 8.30 ± 1.49 
Duf ∆CT2-flag + + ± + ± 4.07 ± 2.15 
Duf ∆CT3-flag - - - - - 1.93 ± 1.00 
Table 3.2 Duf mediated translocation and interaction of Rols and Loner in S2 
cells.  
DA1 nuclei in 40 embryonic hemisegments (10 embryos) were counted in late stage 15 
embryos. Average number of nuclei ± standard deviation is shown. Symbols and 
abbreviations: + = present at site of cell-cell contact, rescues duf,rst mutant to levels 
comparable to that of WT - = not present at site of cell-cell contact, does not rescue duf,rst 
mutant, ± = present only sometimes at site of cell-cell contact, partially rescues duf,rst 
mutant, nt = not tested 
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Interestingly, the expression of Duf ∆CT2-flag  and Duf 4phos-flag  only partially 
restores fusion to an average nuclear number of 4.07 ± 2.15 and 4.61 ± 2.58 
respectively (Figure 3.5D, F and G). It is important to note that Duf ∆CT2-flag lacks 2 of 
the 4 phosphorylation sites mutated in Duf 4phos-flag . These 2 phosphorylation sites are 
Tyr 810 and Tyr 814 that lie in the putative autophosphorylation domain. Transgenes 
in which these two putative phosphorylation sites were mutated together (Duf 2phos-flag) 
and individually mutated, were able to successfully rescue the duf,rst mutant (Figure 
3.5G and data summarised in Table 3.1). Duf ∆CT3-flag that fails to translocate and 
interact with both Rols and Loner (Figure 3.3D, J and Figure 3.4) is only able to 
restore the first phase of myoblast fusion up to the bi/tri-nucleate stage (Figure 3.5E 
and G). These results are also represented as percent hemisegments with DA1 nuclear 
numbers ranging from 1-10 (Figure 3.5H). In WT and rescue with Duf ∆CT1-flag , 
majority of the DA1 muscles contain a high nuclear number ranging from 7-10 while 
Duf ∆CT3-flag shows the reverse, with majority of nuclear numbers ranging from 1-3. 
Rescues with Duf ∆CT2-flag and Duf 4 phos-flag show a high deviation from the mean 
values with nuclear numbers ranging from 1-5 and 1-10 respectively.  
I further investigated if the remaining 90 amino acids or 25% of the 
intracellular domain contributed to the function of Duf and if fusion was further 
compromised upon removal of this region. Truncated Duf forms used to address this 
were Duf ∆CT4-flag and Duf ∆CT5-flag that lacked the intracellular region beyond amino 
acid 610 and 597 removing 96% and 100 % of the intracellular domain respectively 
(Figure 3.2B). It has been shown previously that Duf ∆CT4-flag is able to rescue the 
duf,rst mutant up to the bi/trinucleate stage (Menon et al., 2005). Upon the 
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reintroduction of Duf ∆CT4-flag and Duf ∆CT5-flag  into the duf,rst mutant, the average DA1 
nuclear number is similar to that shown by the expression of Duf ∆CT3-flag (Figure 
3.5G, Table 3.1). But there is a greater percentage of hemisegments (5% v/s 2.5%) 
with 3 and 4 nuclei in embryos rescued with Duf ∆CT4-flag as compared to Duf ∆CT5-flag 
(Figure 3.5H). Even at the terminal stages of fusion at late stage 15,  duf,rst embryos 
rescued with Duf ∆CT5-flag have a maximum of 4 nuclei in their DA1 muscles while 
Duf ∆CT4-flag is able to rescue DA1 muscles up to 5 nuclei (Figure 3.5H). While the 
absence of the intracellular domain does not prevent the formation of bi nucleate 
precursors, they are formed only 30% of the time. In 65% of hemisegments examined, 
fusion completely fails leading to the formation of mononucleate mini muscles. 
Nevertheless, the results with Duf ∆CT5-flag formally demonstrate that formation of 
precursors does not require any part of the Duf intracellular domain. 
 Consistent with the results obtained from S2 cells (Figure 3.3 and Figure 3.4), 
these data suggest that different regions and motifs of Duf intracellular domain 
function additively to bring about efficient myoblast attraction and fusion. Mutation 
of all 4 putative phosphorylation sites partially rescues the duf;rst myoblast fusion 
defect (Table 3.1) implying that phosphorylation of Duf might be one of several ways 
in which myoblast fusion is sustained and myotube growth is regulated. These sites 
appear to be additive in function. Serial truncations of the intracellular domain 
successively compromise the ability of Duf to form a mature muscle. The intracellular 
domain is not required for the formation of bi/trinucleate precursors, in a fraction of 
hemisegments examined. This suggests that the interaction of Duf with Rols and 
Loner is not required for its initial function but is required for increased efficiency of 
the process and the sustenance of myoblast fusion.  The transmembrane domain might 
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serve only to anchor Duf to the FC/myotube membrane. A change in the amino acid 
sequence of this domain does not affect the ability of Duf to perform its function 
during myoblast fusion as long as it is located at the surface of the myoblast/myotube. 
Surprisingly we find that the PDZ binding domain is not required for Duf function in 
myoblast fusion. 
3.3 Discussion 
Previous biochemical studies have shown that Duf interacts with Rols (Chen 
and Olson, 2001). This work shows that Loner too interacts with Duf. I have 
presented evidence that in order to ensure successful fusion a large part of the 
intracellular region of Duf is required for its function. Serial truncations of the 
intracellular domain reveal that the efficiency of fusion is decreased as larger regions 
are removed. The same region of Duf required for efficient fusion is also required for 
binding and localisation of Rols and Loner in S2 cells. It would be interesting to test if 
the translocation of Rols and Loner is similarly affected by the Duf deletion 
constructs, in vivo. 
 This work has also shown that conserved putative phosphorylation signalling 
sites function additively resulting in efficient myoblast fusion and the formation of a 
mature myotube. There are several parallels that can be drawn from this data and that 
published by Kocherlakota et al., (Kocherlakota et al., 2008) on the intracellular 
domain of the Duf ligand Sns. Similar to what has been found for Sns, the well known 
protein-protein interaction motif, the PDZ binding domain is not required for the 
function of Duf during myoblast fusion. This is contrary to the role of this domain in 
the function of Rst in the developing eye. Therefore, while the PDZ binding domain 
of Duf/Rst is not critical for myogenesis, it is required for eye development (Vishnu et 
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al., 2006). While the intracellular domain of Sns is important for its function (Shelton 
et al., 2009), the C terminal end of Sns is dispensable (Kocherlakota et al., 2008) 
similar to that of Duf as shown by Duf ∆CT1-flag in the Rols/Loner translocation assay 
in S2 cells and rescue of the fusion defect in duf,rst embryos. The membrane proximal 
intracellular regions of Sns (Kocherlakota et al., 2008) and Duf are more important 
for their functions. While Sns is phosphorylated on tyrosine residues (Kocherlakota et 
al., 2008), the ability of Duf 4 phos-flag to only partially rescue the duf,rst mutant, 
implies that phosphorylation of these sites also contributes to Duf function. 
Interestingly, membrane anchored forms of Duf irrespective of the sequence 
of the transmembrane domain, appears to be sufficient to ensure successful fusion. 
This suggests that the transmembrane domain of Duf does not perform any essential 
role or contribute to downstream signalling activity and only serves to anchor Duf to 
the plasma membrane. The PADVI motif, though conserved between Duf and Rst, is 
also not important for myoblast fusion. It might have a function in the context of a 
different tissue type that has not been tested so far. That the functions of Duf cannot 
be attributed to particular motifs might be a strategy utilised to ensure normal 
myotube development in animals occurs in a robust manner and compromising the 
function of any of these motifs singly does not drastically affect the overall process. 
As has been suggested for the downstream functions of Sns (Kocherlakota et al., 
2008), Duf too might transduce signals to cytoskeletal elements via its intracellular 
domain, to ensure successful myoblast fusion. The interaction of Duf with Rols and 
Loner, in S2 cells, is dependent on a large part of its intracellular domain.  
Interestingly, the absence of the intracellular domain of Duf does not block 
fusion completely. The extracellular and transmembrane regions alone are sufficient 
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for the initial round of fusion. It is possible that even in the absence of robust Duf 
dependent signal transduction, requirements for the formation of a bi/trinucleate 
precursor are met. The membrane anchored extracellular domain of Duf in Duf ∆CT5-
flag
, might be sufficient to initiate fusion in 35% of hemisegments. This initial function 
of Duf clearly does not require it to interact with Rols and Loner. 
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4 Results: Stages of myoblast fusion may not be molecularly 
distinct: Rolling pebbles and Loner are required for the initial 
round of fusion  
4.1 Background 
Myoblast fusion is a reiterative process. 2-3 FCMs fuse with the FC or the 
growing myotube at any given time. A collection of genes operate at different stages 
of this process. Previous studies proposed that myoblast fusion is divided into two 
distinct steps that require distinct molecules (Rau et al., 2001; Schroter et al., 2004). 
This model proposes that initial myoblast fusion requires certain gene products like 
Duf and Rst and distinct subcellular events, to produce a bi/trinucleate precursor. 
Subsequent myoblast fusion events require a different set of gene products like Rols, 
and subcellular events to undergo additional rounds of fusion until a muscle of the 
correct size is formed. This model is based on the identification of two types of fusion 
mutants, those in which no fusion occurs like the duf,rst mutant and those in which 
some fusion occurs like the rols and loner single mutants. 
Recently it has been proposed that the 2 steps in myoblast fusion may not be 
molecularly distinct. Instead, less frequent fusion events might occur initially 
followed by more frequent events in the later stages giving rise to two temporal 
phases of fusion and that all gene products required for the early phases are likely also 
required for the later phases of fusion. In addition this model proposes that all 
subcellular behaviours like actin foci, prefusion complexes and plaques previously 
identified, are required for all steps of the fusion process (Beckett and Baylies, 2007).  
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This short chapter presents the analysis of myoblast fusion in various mutant 
backgrounds during late stages of myogenesis. Thus far rols has been shown to play a 
role only in the second phase of fusion. While Beckett and Baylies (Beckett and 
Baylies, 2007) have demonstrated that loner mutants show minimal fusion, I show 
here that loner mutants block fusion at stages similar to that observed in rols mutants. 
I also tested if the removal of both rols and loner (rols,loner double mutant) impaired 
fusion further. In addition, the fusion efficiency of other well characterised fusion 
mutants like Drosophila WASp interacting protein (D-wip)/Verprolin 1 
(vrp1)/Solitary (sltr) that block fusion after the formation of the precursor (Kim et al., 
2007; Massarwa et al., 2007) and blown fuse (blow) that occasionally shows 
binucleate precursors (Beckett and Baylies, 2007; Schroter et al., 2004), in 
combination with rols and loner, was analysed.  
These results show that, in a rols,loner double mutant fusion is completely 
blocked and in other double mutants it is significantly compromised. Thus, the 
complex process of myoblast fusion appears to be tightly regulated and its efficiency 
depends on the simultaneous function of several genes. These results support the view 
that there may not be a difference in the requirement of gene products in the early 
versus later phases of fusion and all fusion molecules might be involved in activating 
and sustaining the fusion process albeit through different mechanisms early versus 
later on during myogenesis. 
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4.2 Results 
4.2.1 Rols and Loner have Duf independent functions in the early stages of 
myoblast fusion: 
The present view is that different genes are involved in the early versus later 
stages of myoblast fusion. While it has been suggested that this might not be the case 
and that gene products thus far characterised to be functional in later stages of 
myoblast fusion might also be involved in the initial phase of fusion (Richardson et 
al., 2008a), data conclusively showing this is currently lacking. duf/rst (Ruiz-Gomez 
et al., 2000; Strunkelnberg et al., 2001) and the transcription factor Myocyte enhancer 
factor 2 (Dmef2) (Bour et al., 1995) have been shown to be required for the initiation 
of fusion. In their absence fusion is completely blocked (Bour et al., 1995; Ruiz-
Gomez et al., 2000; Strunkelnberg et al., 2001). mbc has been characterised to be 
involved in the initial phase of fusion (Erickson et al., 1997; Rushton et al., 1995), but 
recent studies have demonstrated the presence of binucleate precursors in mbc mutant 
embryos (Beckett and Baylies, 2007). While rols has been shown to be involved in 
later stages of fusion and in sustaining the fusion cycle (Chen and Olson, 2001; 
Menon and Chia, 2001; Menon et al., 2005; Rau et al., 2001), loner has been shown to 
be required early on during the initial phase of fusion (Beckett and Baylies, 2007; 
Chen et al., 2003). I assessed fusion efficiency by counting the number of nuclei in 
DA1 muscles at late stage 15-early stage 16 of embryogenesis between 13h-14.5h 
after egg laying (AEL). The latest stage of Eve expression was chosen in order to 
determine as closely as possible, the terminal nuclear number in the DA1 muscle. As 
has been reported previously (Bour et al., 1995; Ruiz-Gomez et al., 2000; 
Strunkelnberg et al., 2003), I find that in the duf;rst and Dmef2 mutants fusion is 
completely blocked (Figure 4.1B and Figure 4.2A). It should be noted that the lack of 
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fusion in D-mef2 mutants is probably due to a loss in myoblast differentiation (Lilly 
et al., 1995; Nguyen et al., 1994). Consistent with data presented by Becket and 
Baylies (Beckett and Baylies, 2007) I find that fusion is blocked at the precursor stage 
in an mbc mutant (Figure 4.1L, Figure 4.2A and B). In a rols single mutant fusion is 
blocked at the precursor stage (Figure 4.1C). Upon investigation of the loner mutant, 
unlike previous reports, I observe a higher frequency of bi/trinucleate precursors 
(Figure 4.1D). It is important to note that this difference in observations is due to the 
precise time point at which DA1 nuclei were counted. Previous reports have 
performed this analysis at stage 14-15 (10.5h-13h AEL) and I have confirmed their 
findings. However, I further analysed the loner mutant (and all other mutants 
mentioned below) at later stages of embryogenesis (13h-14.5h AEL) in order to 
minimize effects caused by delay in fusion. 
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Figure 4.1 . Fusion in single and double mutant backgrounds.  
Late stage 15-early stage 16 embryos with somatic muscles and FCM labelled with 
anti-MHC (red) and anti-eve (green). Wild type DA1 muscle with approximately 10 
nuclei per muscle (A). duf,rst embryos with uninucleate DA1 muscles (B). rols, loner, 
D-wip,blow and mbc single mutants (C-F and L). (G-K) rols,loner, blow;rols, 
blow;loner, D-wip;rols and D-wip;loner double mutants with reduced number of eve 
positive nuclei. The pericardial cells are also labelled with anti-eve but are 
distinguished by their brighter stain and are not surrounded by MHC positive muscle 
cytoplasm. Scale bar = 20um. 
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Figure 4.2 Fusion efficiency is compromised in double mutant backgrounds.  
Average number of Eve positive nuclei in the listed mutants, at late stage 15-early 
stage 16 (A). Distribution of nuclear numbers in the listed mutants at late stage 15-
early stage 16 (B). Fusion efficiency is significantly compromised in the double 
mutants. 
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To test if fusion is further impaired in the absence of combinations of such 
molecules and if they have functions during the initial phases of fusion, double 
mutants were generated by recombining the rols deficiency allele rolsDf(3L)BK9 and the 
loner EMS allele loner T1032, henceforth called the rols,loner mutant. In addition 
double mutants combining the P element excision allele D-wip D30 and a blown fuse 
allele blow 2 with rolsDf(3L)BK9 and loner T1032 were generated, henceforth called the D-
wip;rols, blow;rols, D-wip;loner and blow;loner mutants. Myoblast fusion in these 
double mutants was compared to the single mutants.  
While WT DA1 shows an average of 9.5 ± 1.56 nuclei (Figure 4.1A and 
Figure 4.2A), the rols and loner single mutants block fusion at the bi/trinucleate stage 
with an average nuclear number of 2.89 ± 0.91 and 2.11 ± 0.91 respectively (Figure 
4.1C, D and Figure 4.2A).  Interestingly, in the rols,loner double mutant fusion is 
completely blocked (Figure 4.1G and Figure 4.2A) and founders remain 
mononucleate, similar to the duf,rst mutant (Figure 4.1B and Figure 4.2A). In both 
these mutants FCMs do not appear to be attracted towards the FC as indicated by the 
morphology of their lamellipodia which are randomly oriented (Figure 4.1B and G). 
While fusion in D-wip embryos is blocked at the precursor stage (Kim et al., 2007; 
Massarwa et al., 2007) (Figure 4.1E and Figure 4.2A) and blow embryos show rare 
fusion events upto the binucleate stage (Beckett and Baylies, 2007) (Figure 4.1F and 
Figure 4.2A), fusion is significantly compromised in the D-wip;rols, blow;rols, D-
wip;loner and blow;loner double mutants (Figure 4.1G-K and Figure 4.2A). There is 
a significant reduction in nuclear number as compared to the single mutants (Figure 
4.2A). While the average nuclear number is indicative of overall fusion in an embryo, 
we also chose to analyse these mutants by calculating the percentage of hemisegments 
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that showed a specific number of nuclei ranging from 1-5. We find that there is a 
greater percentage of hemisegments with a reduced number of nuclei in the D-
wip;rols, blow;rols, D-wip;loner and blow;loner double mutants as compared to the 
D-wip, blow, rols and loner single mutants (Figure 4.2B).  
These results, summarised in Table 4.1, have the following implications. Thus 
far, besides the transcription factor Dmef2 (Bour et al., 1995) , duf and rst are the only 
other genes that are essential for the initiation of fusion. duf (and rst) appears to be the 
limiting factor during fusion in the absence of which fusion is completely blocked 
(Ruiz-Gomez et al., 2000; Strunkelnberg et al., 2001). Importantly, we now show that 
Rols and Loner also function during the initial stages of myoblast fusion in a manner 
independent of Duf. 
Fusion mutants Avg. number of DA1 
nuclei 
WT 9.50 ± 1.50 
duf,rst 1.00 ± 0.00 
Dmef2 1.00 ± 0.00 
mbc 1.07 ± 0.26 
blow 1.55 ± 0.61 
rols 2.89 ± 0.91 
loner 2.11 ± 0.91 
D-wip 3.52 ± 0.82 
rols,loner 1.00 ± 0.00 
blow;rols 1.18 ± 0.48 
blow;loner 1.08 ± 0.28 
D-wip;rols 1.55 ± 0.65 
D-wip;loner 1.25 ± 0.55 
Table 4.1 Average number of DA1 nuclei in fusion mutants at late stage 15-early 
stage 16.  
DA1 nuclei in 45 hemisegments (~11 embryos) were counted in embryos at late stage 
15-early stage 16. Average number of nuclei ± standard deviation is shown. 
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4.3 Discussion 
Thus far it has been shown that myoblast fusion molecules can be categorised 
into those that participate in the early versus later phases of fusion (Beckett and 
Baylies, 2007). I have shown that removal of both rols and loner completely blocks 
fusion similar to the duf;rst mutant. This suggests that rols and loner have functions 
that are independent of duf during the initial round of fusion. Analyses of other 
similar double mutants demonstrate that genes involved in myoblast fusion might 
interact with each other to affect fusion efficiency. It is possible that what we have 
shown here with a few myoblast genes is true for other genes that have thus far been 
characterised for their role in the later stages of fusion. Such interactions have been 
shown for kette/hem/nap1/gex-3 and blow (Schroter et al., 2004).  
Thus while membrane anchored Duf without its intracellular domain and 
without any interaction with Rols and Loner, forms precursors in a duf,rst mutant 
background, we also show that Rols and Loner are required, albeit redundantly, for 
precursor formation or the initial phase of fusion suggesting that this “early function” 
of these molecules appears to be independent of Duf. We have observed this fusion 
defect in late stage 15-early stage 16 embryos to ensure that our observations and 
interpretation thereof are not due to a delay in fusion.  Rols and Loner seem to 
perform different roles early versus later on during myoblast fusion. In the later phase 
of fusion, Rols (Menon et al., 2005) and Loner (Chen et al., 2003) appear to sustain 
fusion by interacting with and translocating Duf to the surface of the myotube (Chen 
et al., 2003; Menon et al., 2005) (this work). As has been suggested in the case of 
Rols (Menon et al., 2005), Loner too might serve to regulate Duf at the surface of the 
myotube through as yet unknown mechanisms. 
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5 Results: Muscle wasted: A novel component of the Drosophila 
histone locus body required for muscle integrity. 
5.1 Background 
The formation of mature tissues and cell types requires the establishment and 
maintenance of complex spatiotemporal patterns of gene expression. Cells undergo a 
regulated series of steps leading to terminal differentiation. This includes permanent 
withdrawal from the cell cycle and the stable repression of many genes involved in 
cell cycle control. At the same time genes involved in the activation of cell 
differentiation and the maintenance of the differentiated phenotype, are newly 
synthesised. This is accompanied by changes in chromatin organisation that arise as 
previously active genes are silenced and new genes are transcribed.  
During myogenesis myoblasts are faced with the tremendous task of cell 
fusion and reorganisation of the genome, as the myotubes grow in size. When FCs 
fuse with FCMs, the nuclei of the FCMs are reprogrammed to express FC identity 
genes. Simultaneously these growing myotubes express genes involved in terminal 
differentiation, events that include myotube growth and extension, attachment, 
formation of the sarcomere and neuromuscular junctions. These events give rise to the 
functional contractile muscle. The specialisation of muscle tissue and maintenance of 
function is achieved through the expression of cell type specific genes. Dmef2 is 
expressed throughout myogenesis and genetic studies have highlighted its essential 
role during this process (Elgar et al., 2008; Sandmann et al., 2007). In the absence of 
Dmef2, differentiation of all muscle lineages is blocked (Bour et al., 1995; Lilly et al., 
1995). Studies have shown that Dmef2 is expressed during terminal muscle 
differentiation and appears to regulate the expression of several muscle genes. Histone 
 Chapter 5 Results: Muscle wasted  
 94 
modifications have been implicated in the regulation of vertebrate Mef2 expression 
(Haberland et al., 2007). While histone turnover is maximal in dividing cells, to 
ensure packaging of newly replicated DNA, there is no reason to exclude the 
possibility of histone turnover in differentiated cells, though the turnover might be 
slower in non proliferating cells. Histone levels are controlled largely by regulating 
their mRNA levels. The mRNAs encoding histones are a unique set of transcripts in 
metazoans. They are the only mRNAs that do not end in a polyA tail. The pre-
mRNAs undergo a single processing reaction, an endonucleolytic cleavage to form 
the 3’end of the mature transcript. Several proteins unique to histone mRNA 
processing have been described, like the Stem Loop Binding Protein (Slbp) and the 
U7snRNP complex (which includes the U7snRNA, Lsm10 and Lsm11) that appears 
to recruit the endonuclease that catalyses pre-mRNA cleavage. 
The Cajal body (CB), a nuclear organelle first described in 1903 by the 
Spanish neurocytologist, Santiago Ramòn y Cajal remained shrouded in mystery until 
the discovery of the CB marker Coilin, a couple of decades ago (Andrade et al., 
1991). Small ribonucleoproteins (snRNPs), like the U7snRNP, that carry out pre-
mRNA splicing are highly concentrated in the CB (Cioce and Lamond, 2005; Stanek 
and Neugebauer, 2006). Recent evidence suggests that CBs are nuclear sites of RNP 
assembly and remodelling (Cioce and Lamond, 2005; Stanek and Neugebauer, 2006). 
Drosophila CBs also include similar components, like Coilin, but the U7 snRNP 
associates with a separate nuclear body, the histone locus body (HLB), which is 
closely associated with the histone genes.  
This chapter presents the isolation and characterization of muscle wasted 
(mute) that appears to be a novel component of the HLB. Animals that lack mute 
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function show the progressive loss of muscle mass including rounded detached 
muscles during late embryonic development. While the early differentiation of 
myoblasts is not affected terminal differentiation appears to be defective. I show by 
immunofluorescence analysis and quantitative RT-PCRs that Dmef2 and other genes 
involved in terminal muscle differentiation are downregulated. In addition we also 
find an increase in levels of the predicted Drosophila homologue of atrogin-1, shown 
to be upregulated in vertebrate models of skeletal muscle atrophy (Glass, 2003; 
Gomes et al., 2001). We find a significant increase in the levels of mis-processed 
histone transcripts and aberrant localization of the heterochromatin protein 1(HP1). I 
propose that changes in heterochromatin might lead to genome instability and the mis 
regulation of muscle genes. I also show genetic interactions between mute and slbp 
and the loss of striations in the larval muscles of lsm11 mutants. Thus far the role of 
these processing factors has largely been characterized in dividing cells or during 
oogenesis both known for their requirements of large amounts of histone proteins. To 
my knowledge, this is the first report supporting the role of these processing factors in 
differentiated muscles. 
5.2 Results  
5.2.1 mute is required for maintenance of muscle mass and integrity:  
To identify novel genes involved in myogenesis, a genetic screen was 
performed, using EMS-mutagenised Drosophila lines. Embryonic lethal lines were 
selected for the analysis of the somatic muscles. Embryos homozygous for an allele 
1281, showed a severe loss of muscle mass during the late stages of embryogenesis. I 
named this locus muscle wasted (mute) and the EMS allele as mute1281. In order to 
define this phenotype more precisely, somatic muscles were analysed from stage 14, 
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during the peak of myogenesis, up to the end of embryogenesis at stage 17, when the 
muscles are fully developed and begin to contract. Df(2R)Exel 6065 (breakpoints 
53D14-53F8) produced the degenerative muscle phenotype when in trans with the 
EMS allele mute1281 (mute1281/Df). mute1281/Df embryos were analysed in all 
experiments hereafter. The size and shape of the dorsal muscles DO, outlined in 
dashed lines and DA, outlined in solid lines in Figure 5.1, were compared. At stage 
14, no significant difference in muscle morphology or mass was observed between 
mute1281/Df and wild type (WT) embryos (Figure 5.1A and B). By stage 15, some 
muscles appeared thinner than their WT counterparts (outlined in Figure 5.1C and D). 
Also some muscles were no longer detectable in mute1281/Df embryos (asterisks in 
Figure 5.1D). Though only the dorsal muscles have been shown at these stages 
(Figure 5.1A-D), it should be noted that most somatic muscles showed similar defects 
(data not shown for stages 14 and 15). At stage 16 many muscles appeared 
significantly thinner in mute1281/Df embryos compared to their WT counterparts 
(Figure 5.1E-J, outlined). There was no bias towards any specific muscle type. Dorsal, 
lateral and ventral groups of muscles were equally affected though the manifestation 
of the phenotype was variable (Figure 5.1F, H and J). While ~60% of the muscles 
were significantly thinner than their WT counterparts (compare Figure 5.1E, G, I to F, 
H, J, outlined), 20% appeared to be detached at least at one end of the myotube and 
~10% appeared to be detached at both ends (Figure 5.1F, H and J, arrows). Due to the 
reduced muscle mass, gaps between muscle subsets were larger which made the 
underlying visceral mesoderm more visible (indicated by ‘v’ in Figure 5.1F and H). 
The severity of the phenotype increases concurrently with the age of the embryo. At 
stage 16 there were more muscles that could not be detected (Figure 5.1F, J, asterisk). 
To observe the musculature after the deposition of the cuticle, a cytoplasmic GFP 
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reporter was expressed under the control of the myosin heavy chain (mhc) promoter 
(Figure 5.1K and L). By stage 17, the muscles degenerated to an extent where the WT 
pattern, (shown in Figure 5.1E, K and  the schematic, Figure 5.1M, was no longer 
recognizable (Figure 5.1L). All the muscles lost their characteristic WT morphology 
(Figure 5.1K) and appeared spherical in shape (Figure 5.1L, asterisk) or became 
extremely thin (Figure 5.1L, arrowhead). More than half the muscles eventually 
fragmented into small blebs (Figure 5.1L, arrow). These morphologies are 
characteristic of degenerating muscles (Carrasco-Rando and Ruiz-Gomez, 2008; 
Nguyen et al., 2007). Approximately 95% of mute1281/Df embryos were unable to hatch 
(n = number of embryos = 19/20). The remaining 5% hatched almost 12 hours after 
their WT counterparts. These larvae displayed abnormal and sluggish movements and 
died soon after hatching. 
Thus, the muscle wasting phenotype in mute1281 is manifest late in embryonic 
development. The muscles degenerate completely at the end of embryogenesis. It is 
possible that a maternal contribution of mute masks a possible early phenotype. I was 
unable to ascertain this since mute1281germ line clones do not develop into mature 
eggs.  
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Figure 5.1 Progressive loss of muscle mass in mute1281 mutants: 
(A,C,E,G,I) Wild type (WT) and (B,D,F,H,J) mute1281/Df somatic muscles labeled with 
anti-Myosin Heavy Chain (MHC) (red). DO and DA muscles are outlined in dashes 
and solid lines respectively. (A,B) At stage 14 muscle mass in mute1281/Df is 
comparable to that in WT. (C,D) By stage 15 some muscles start to appear thinner 
than their WT counterparts. (E-J) At stage 16 muscles are significantly thinner in 
mute1281/Df compared to WT muscles. (E,F) Dorsal, (G,H) lateral, and (I,J) ventral 
groups are equally affected. Muscles are significantly thinner (F,H,J, outlined). Gaps 
between muscles begin to appear (D, asterisk). Some muscles appear to be missing 
(F,J, asterisk). Gaps are wider with the underlying visceral mesoderm more visible 
(F,H, ‘v’). (K, L) Stage17 WT and mute1281/Df somatic muscles labeled with an MHC-
GFP reporter. Compared to WT mute1281 muscles are significantly thinner and show 
abnormal morphologies. Many are detached and rounded eventually forming blebs (L, 
arrow). Some are extremely thin (L, arrowhead). (M) Schematic representation 
depicting the larval/embryonic somatic muscles. In all images anterior is left and 
dorsal is up. Vertical white bars demarcate segment boundaries. Scale bar =20um 
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5.2.2 Molecular cloning of mute: 
Mute was mapped to the right arm of chromosome 2. The coding regions of several 
predicted genes in the chromosomal region of Df(2R)Exel 6065 (breakpoints 53D14-
53F8), were sequenced. This led to the identification of a mutation in CG34415 that 
lies at the 53E2 locus (Figure 5.2A). A base change from C to T was detected at 
position 559 of the coding sequence. CG34415 spans ∼6.8kb of the genome and is 
predicted to encode two isoforms that we verified by Northern analysis using total 
RNA extracted from staged WT embryos (Figure 5.2C). We named these isoforms 
mute-L (Long) and mute-S (Short). Both mute-L and mute-S are expressed at early 
stages of embryonic development from 0-5 hours after egg laying (AEL) and are not 
detectable at later stages from 14-17 hours AEL (Figure 5.2C). mute-L migrates at 
approximately 5.5kb while mute-S at approximately 3.3kb (Figure 5.2C).  Mute-S is 
identical to the C terminal region of Mute-L (Figure 5.2A, filled in black).  
The mutation in mute1281 changed amino acid Q187 to a premature stop codon 
(TAA) which is predicted to produce a truncated protein (Figure 5.2A, red triangle). 
This mutation lies in a region that is unique to mute-L. A P element insertion 
P{GawB}NP1160 lies 90 bases upstream of the ATG of Mute-L also resulted in a 
similar degenerative muscle phenotype when present in trans with mute1281 (Figure 
5.2A, green triangle and data not shown). mute-L and mute-S encode predicted 
proteins that are 1739 and 665 amino acids in length, respectively (Figure 5.2B). 
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Figure 5.2 Organisation of the mute locus and structure of Mute:  
(A) The mute locus is at 53E2 on the right arm of chromosome 2. CG34415 encodes 
for the 2 isoforms, mute-L and mute-S. mute-L has a unique N terminal region (blue). 
The C terminal region is shared between both isoforms (black). The EMS allele 
mute1281 has a C to T change at position 559 of the coding sequence leading to the 
presence of a premature stop codon TAA (red triangle), depicted as mute1281 with a 
premature stop at amino acid 187. The P element P{Gaw}NP1160 is inserted 90 bases 
upstream of the ATG of mute-L (green triangle). mute-S has a predicted 5’UTR and 
the same 3’UTR as mute-L (white boxes). The coloured bars under mute-L indicate 
the domains depicted in B. (B) Protein structure depicts a 1739 amino acid Mute-L 
and 665 amino acid Mute-S. The N terminal half of Mute-L is weakly homologous to 
Atrophin-1 from amino acid 216-1088. Mute-L and Mute-S have two paired 
amphipathic helix (PAH) repeats from amino acids 1121-1198 and 1204-1279 and an 
extreme C terminal homeodomain like (amino acid 1657-1735)/SANT DNA binding 
domain (amino acid 1680-1732). (C) Northern blot using total RNA from WT 
embryos at the indicated time points. The probe used was directed against the 3’-
terminus of mute-L and mute-S. These two isoforms are expressed at early stages of 
embryonic development. No expression is detected at later stages. Sizes indicated are 
approximations in kb. 
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            Sequence homology searches using the Simple Modular Architecture Research 
Tool (SMART) revealed that the N terminal region of Mute-L (amino acid 216-1088) 
is weakly homologous to the Atrophin-1 protein family. The C terminal region from 
amino acid 1680-1732 is weakly homologous to the SANT (Swi3, Ada2, N-CoR and 
TFIIIB) DNA binding domain. The scores for both these homologies are less 
significant than the required threshold. InterPro predicts the presence of a 
homeodomain like region from amino acids 1657-1735 of Mute-L and two paired 
amphipathic helix (PAH) repeats from amino acids 1121-1198 and 1204-1279. These 
regions are common between Mute-L and Mute-S (Figure 5.2B). Some PAH repeat 
containing proteins are known to function as components of co-repressor complexes 
in transcriptional silencing (Wang et al., 1990). SANT and homeodomains have been 
shown to function in the regulation of transcription. Interestingly BLAST searches 
revealed that the PAH repeats of Mute-L are 28% identical to that of the PAH-like 
repeats of zebrafish Ugly duckling (Udu) a nuclear protein required for somite 
morphology (Lim et al., 2009; Liu et al., 2007) and 27% identical to that of human 
GON4L or YARP (YY1AP-related protein1) a nuclear protein with suggested 
transcriptional regulator like functions. Figure 5.3 depicts this alignment. 








Figure 5.3 PAH domain homology 
Clustal W alignment of the paired amphipathic helix (PAH) domain of Drosophila 
(Dme) Mute-L with that of human (Hs) GON4L (GenBank accession number: 
AAI17558) and the PAH-L domain of zebrafish (Dr) Ugly duckling (Udu) (GenBank 
accession number: ABP65284). Higher the colour intensity higher is the similarity. 
The black boxes indicate Mute-L PAH repeats. The PAH repeats of Mute-L are 28% 
identical to that of Udu and 27% identical to that of GON4L 
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To further confirm that the observed muscle defects were due to a mutation in 
CG34415, transgenic lines carrying mute-L and mute-S under the regulation of the 
UAS promoter, were generated. All UAS constructs were expressed under the control 
of the mesodermal drivers 24BGAL4 and rp298GAL4 which carry the yeast GAL4 
under the held out wings (how) and dumbfounded (duf) promoters, respectively. 
Expression of mute-L in mute1281/Df embryos in the presence of 24B-GAL4 or rp298-
GAL4 completely rescued the muscle wasting phenotype Figure 5.4A and C) giving 
rise to normal muscles (n = number of embryos= 12/12) that were comparable to WT 
(Fig. 3B). mute-S rescued the muscle defect in only 18% of the embryos (n = 2/11) 
(Figure 5.4A and E, arrows). In order to test the possible role of the SANT DNA 
binding/homeodomain-like region, a construct that deleted this region (mute∆C) was 
similarly introduced into the mute1281/Df background. I found that mute∆C was 
completely able to rescue the muscle defect (n =10/10) (Figure 5.4A and F). A 
truncated construct with a premature stop in the Atrophin-1 like region that removed a 
larger region of mute-L, completely failed to rescue the muscle defect (n = 0/10) 
(Figure 5.4A and G). These results demonstrate that the observed muscle defect is due 
to the mutation in CG34415 that affects mute-L. mute-S may be able to compensate 
weakly for the function of mute-L although in the majority of mutant embryos 
expression of mute-S was unable to rescue the muscle defect (Figure 5.4A). I have 
also shown that the homeodomain-like/SANT DNA binding region may not be 
important for the function of mute in the somatic muscles.  






Figure 5.4 Figure 3: Mute-L rescues the muscle wasting defect: 
(A) Schematic representation of UAS-mute constructs used to rescue mute1281. 
Numbers indicate amino acid length of the construct. Number of embryos (expressed 
as percent) rescued is indicated. (B-G) Dorsal muscles of stage 16 embryos labeled 
with anti-MHC (red). All constructs are expressed in mute1281/Df embryos using 24B 
GAL4 at 25oC. UAS-mute-L rescues the muscle wasting defect (D) observed in 
mute1281/Df (C) to a level comparable to that observed in WT embryos (B). UAS-mute-
S fails to rescue the muscle defect as shown by the persistence of thin muscles (E, 
arrows). UAS-mute∆C that lacks the homeodomain-like region is able to rescue the 
muscle defect (F). UAS-mute∆C Atro, a truncated form of mute-L, fails to rescue the 
muscle defect (G). scale bar = 20um. Dorsal is up, anterior is left. 
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Late differentiation is defective in mute1281: 
In order to determine if the late muscle wasting phenotype is caused by defects 
in early versus late myogenic events, I tested various aspects of myogenesis from 
early specification to late differentiation. The overall numbers of somatic, cardiac and 
visceral muscle progenitors in the early mesoderm was unaffected as shown by the 
expression of DMef2 (Figure 5.5A and B). The enhancer trap line, rp298-lacZ was 
used to label all founder myoblasts. I found that there was no significant difference in 
founder myoblast numbers at stage 12 during early myogenesis (Figure 5.5C and D). 
D-Titin a muscle structural marker is expressed in fusion competent myoblasts and 
also in the developing myotube. There was no significant difference in the number of 
fusion competent myoblasts at stage 14 of myogenesis when myoblast fusion is at its 
peak (Figure 5.5 E and F). I examined muscle specification by using markers that 
label specific muscle subsets. The DA1 muscles were correctly specified as observed 
by the expression of the DA1 specification marker Even skipped (Eve) in the muscle 
nuclei at stage 13 (Figure 5.5G and H). Similar results were obtained using the DO1 
marker, Kruppel (not shown).  
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Figure 5.5 Myoblast specification is not affected in mute1281 
(A,C,E,G) WT and (B,D,F,H) mute1281/Df embryos at the indicated stages of 
development labeled with the indicated markers. (A,B) Muscle progenitor numbers in 
mute1281/Df are comparable to that observed in WT using anti-Dmef2 (green), at stage 
12. (C,D) Founder myoblast numbers in mute1281/Df are comparable to those observed 
in WT as shown by the B-gal positive stain (green) using the enhancer trap rp298-
lacZ at stage12. (E,F) Fusion competent myoblasts are correctly specified as indicated 
by the expression of D-Titin (red) at stage 14. (G,H) DA1 nuclei are correctly 
specified as shown by the expression of the DA1 marker Eve (green, outlined). 
Brighter Eve positive cells lying adjacent to the DA1 nuclei, are pericardial cells. 
Scale bar = 20um. 
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I next asked if late specification and differentiation of the mute myotubes was 
affected. The DA1 muscle nuclei at stage 16 continued to express Eve (Figure 5.6A 
and B). Even as muscles started to lose their mass, Eve expression was sustained and 
there was no significant decrease in nuclear number. A small fraction (1 in 7 DA1 
muscles) of abnormally shaped muscles showed a more drastic reduction in Eve 
positive nuclei (Figure 5.6, arrow). Importantly, the expression of DMef2 was 
reduced in the nuclei of mature mute1281/Df myotubes (Figure 5.6D) compared to WT 
(Figure 5.6C). As myogenesis proceeds muscles extend and attach to specialized 
epithelial cells, the tendon cells, during the late stages of myogenesis. D-Titin labels 
the mature myotube and is enriched at sites of muscle-tendon attachment at these late 
embryonic stages. As observed in WT muscles I detected the expression of D-Titin in 
the thinner muscles of mute1281/Df embryos at late stage 16 (Figure 5.6E and F). But I 
observed uneven cytoplasmic expression (Figure 5.6 E and F, arrowheads) and a 
reduction in the enrichment of D-Titin at the myotube attachment sites (Figure 5.6E 
and F, arrows). I verified this by using another attachment site marker, Kettin. The 
reporter line, Kettin-GFP also showed a reduction in Kettin expression, at muscle 
attachment sites compared to WT (Figure 5.6G and H, arrows).  I did not observe any 
defects in the general organization of the epithelium when muscles were thinner than 
normal (Figure 5.7 A-F) as shown by anti-Discs large (Dlg) staining, which labels 
epithelial junctions. Changes in cell shape from columnar to cuboidal were apparent 
only when muscles were detached from their attachment sites at late stage 16 (Figure 
5.7 G-I, arrows). 
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Figure 5.6 Late muscle differentiation is defective in mute1281 
(A,C,E,G) WT and (B,D,F,H) mute1281/Df late stage 16 embryos. Dorsal muscles 
labeled with anti-MHC (red; A-D,G-H) or D-Titin (red; E,F), and the indicated 
markers in green. (A,B) Mature myotubes continue to express Eve (green). Outlined 
are the DA1muscles. Occasionally abnormally shaped muscles show a reduction in 
Eve positive nuclei (B, arrow). (C,D) Dmef2 (green) marks the nuclei of all 
myotubes. Its level of expression is reduced in mute1281/Df (D) compared to WT (C). 
(E,F) Myotubes continue to express D-Titin at stage 16 although the enrichment of D-
Titin at the attachment sites is reduced in mute1281/Df (E,F,arrow). (G,H) Kettin-GFP 
(green) also labels the attachment sites. Kettin enrichment is markedly reduced in 
mute1281 (H) compared to WT (G). Vertical white bars demarcate segment boundaries. 
Scale bar = 20um. 
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Figure 5.7 Epithelial defects are restricted to regions overlying detached muscles 
(A-C) WT (D-I) mute1281/Df late stage 16 embryos. Epithelium labeled with anti-Dlg 
(green) and dorsal muscles with anti-MHC (red). Epithelial cells overlying WT 
muscles (A-C) and mute1281/Df thinner muscles (D-F) are columnar in shape while 
those overlying muscles that are detached and rounded are more cuboidal in shape (G-
I, arrows). Scale bar = 20um 
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Thus, the specification of myoblasts and muscles is unaffected in mute1281. 
The thinning muscles continue to express myotube specification markers. Hence the 
loss in muscle mass is neither due to defective myoblast specification nor due to the 
inability to maintain the expression of specification genes in myonuclei. Late 
differentiation is affected as observed by a reduction in DMef2 expression and 
attachment site markers concurrently with muscles that are detached. Changes in 
epithelial cell shape are restricted to regions overlying detached muscles. It is possible 
that these defects result in the inability of mature muscles to maintain their integrity. 
5.2.3 mute1281 muscles do not undergo apoptosis: 
It has been shown previously that apoptotic markers are upregulated in 
degenerating muscles (Nguyen et al., 2007). I asked if the same was true in mute1281. I 
addressed this by performing Tunel stainings and using anti-caspase3 antibodies to 
check for apoptosis in the thinning muscles. Anti-caspase3 labelled cells in both WT 
and mute1281/Df embryos, below the plane of the myotubes. These are probably fusion 
competent myoblasts given their location in the embryo (Figure 5.8A and B, 
arrowheads). Tunel stains also gave similar results (not shown). Neither of these 
apoptotic markers labeled the myotubes at stage 16 when the muscles showed an 
obvious loss in mass. In addition I also tested if the muscle wasting defect was 
rescued by removing grim, reaper (rpr) and head involution defective (hid), the key 
regulators of apoptosis in Drosophila, using the chromosomal deficiency H99. Double 
mutants homozygous for mute1281 and H99 continued to show the presence of thin 
muscles characteristic of mute1281/Df  (Figure 5.8C and D). This suggests that the 
muscle wasting defect observed in mute1281 is not due to apoptosis in the myotubes.









Figure 5.8 mute1281 muscles do not undergo apoptosis 
(A) WT and (B) mute1281/Df late stage 16 embryos. Dorsal muscles labeled with anti-
MHC (red) and anti-Caspase-3 (green). Caspase-3 positive cells are detected below 
the plane of the muscles in mute1281/Df (B,D, arrowheads). Their position suggests that 
these might be fusion competent myoblasts. (C,D) Late stage 16 embryos. Dorsal 
muscles labeled with anti-MHC (red). Embryos homozygous for Df H99 that removes 
grim, rpr and hid do not display any visible muscle defects (C). mute1281/Df;Df H99 
double mutants display thin muscles even in the absence of apoptotic activators (F). 
scale bar = 20um 
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5.2.4 Motor neuron terminals are defective in mute1281  
Terminal differentiation of muscles includes the establishment of 
neuromuscular junctions (NMJ). Transmission of the motor neuron impulse across the 
synapse leads to muscle contraction. A series of events including axon outgrowth and 
guidance, exploration, target selection, pruning and the localisation of pre- and post-
synaptic molecules lead to the formation of the mature NMJ. Muscles are not required 
for motor neurons to reach their target site but are required for the formation of stable 
synapses when axon terminals probe the muscle surface and withdraw inappropriate 
contacts. Post synaptic receptors fail to localise in the absence of motor neuron 
innervation (Broadie and Bate, 1993a). In order to assess possible defects in the 
formation of the neuromuscular junction, motor neurons were studied using anti-horse 
raddish peroxidase (HRP). In WT embryos at stage 16, axonal branches of the 
intersegmental nerve (ISN) form thick growth cones at the surface of the dorsal 
muscles  in a segmentally reiterated pattern (Figure 5.9A, arrow) and axon 
arborisation is consolidated onto the target muscle (Figure 5.9C) . In mute1281/Df 
embryos the ISN appears to target the correct muscles but growth cones appear wispy 
and are not well defined (Figure 5.9B, arrows). It has been shown that ectopic 
synapses are formed on neighbouring muscles when their target muscles are 
surgically deleted (Cash et al., 1992). In mute1281/Df, occasional ectopic projections are 
observed when the target muscle is significantly thinner (Figure 5.9D, arrowhead). 
Perhaps the loss of muscle mass leads to these ectopic synapses or motor axon 
pruning is defective.  






Figure 5.9 Motor neuron terminals are not well defined in mute1281 
(A-D) Stage 16 WT (A, C) and mute1281/Df (B,D) embryos. Motor neurons labelled 
with anti-HRP (A,B, green C,D, red), muscles with anti MHC (A,B, red C,D blue) 
and DA1 nuclei with anti-Eve (C,D, green). Motor neuron axons terminating on 
dorsal muscles are well defined in WT (A, arrow), but are very poorly defined in 
mute1281/Df (B, arrows). In some instances ectopic axon branching is observed (D, 
arrowhead) unlike the well matched target selection in WT (C). DA1 muscles are 
outlined in white lines. Vertical bars indicate segment boundaries. Scale bar = 20um. 
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5.2.5 Mute is a nuclear protein:  
Antibodies were generated against the N (anti-Mute-L, amino acids 3-164) 
and C terminus (anti-Mute-LS, amino acids 1093-1291) of the mute coding sequence 
and used to study Mute protein expression pattern in embryos and larvae. Anti-Mute-
L recognizes the N terminus of Mute-L while anti-Mute-LS recognizes the C terminus 
that is common to both Mute-L and Mute-S. I tested these antibodies in WT embryos. 
Anti Mute-L detects a nuclear protein that is expressed as a prominent nuclear focus 
in all cells of the embryo. Shown in Figure 5.10 are the results obtained from late 
stage 16 embryos. A single nuclear focus was clearly observed in WT somatic 
muscles (Figure 5.10A, arrow). This expression was undetectable in mute1281/Df 
embryos (Figure 5.10E, arrow). A similar pattern was detected using anti-Mute-LS 
antibodies (Figure 5.10B) with significantly reduced levels of protein in mute1281/Df 
embryos (Figure 5.105F). The anti-Mute-L and anti-Mute-LS positive foci overlap in 
both muscle (Figure 5.10C, arrow) and non muscle (Figure 5.10C, arrowhead) nuclei. 
Protein expression in the mutant was restored by rescue with  UAS-Mute-L expressed 
under 24B-GAL4, which drives expression in muscle and tendon cells  (Figure 
5.10G). In these embryos, in addition to the nuclear focus there is a diffuse nuclear 
stain, probably due to overexpression of the protein. The nuclear focus is recovered in 
muscle (Figure 5.10G, arrows) and tendon cell (Figure 5.10G, arrowhead) nuclei. To 
assess if Mute associates with DNA, its localization was tested in the larger salivary 
gland nuclei of WT third instar larvae. I found that Mute was localised to a single 
locus associated with the large polytene chromosomes (Figure 5.10H). Thus, the 
antibodies generated against Mute label a specific nuclear organelle/body and Mute 
appears to associate with a specific chromosomal locus 
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Figure 5.10 Mute is a nuclear protein 
(A-G) Stage 16 dorsal muscles labeled with anti-MHC (red) and DNA labeled with 
Hoechst (blue). Insets are magnified regions of the same. Scale bar = 10um.WT 
embryos labeled with anti-Mute-L (A, pink) and anti-Mute-LS (B, green) show the 
expression of Mute in a discrete nuclear focus/body in all nuclei (arrows). This 
expression using anti-Mute-L is undetectable (E, arrow) and using anti-Mute-LS is 
highly reduced (F, arrow) in mute1281/Df embryos. Both antibodies label the same 
structure as shown by the colocalisation of the nuclear foci (yellow)(C, arrow-muscle, 
arrowhead-non muscle). This expression is recovered in muscle (G, arrow) and 
tendon cell (G, arrowhead) nuclei in mutant embryos rescued with UAS-Mute-L 
driven by 24B-GAL4. (H) Salivary gland nucleus labeled with anti-Mute-LS (green), 
Hoechst (blue) and Lamin (red) shows the presence of a single Mute positive locus 
associated with the polytene chromosomes (H, arrow). Scale bar in C = 10um. 
Vertical bars indicate segment boundaries. Anterior left, dorsal up.  
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5.2.6 Mute is a novel component of the histone locus body: 
The nuclear expression of Mute was reminiscent of the localization patterns of 
components of two nuclear bodies, the Cajal body (CB) and the histone locus body 
(HLB). In order to test if Mute was a component of either of these nuclear bodies, I 
asked if Mute colocalised with markers for these nuclear structures. Lsm10 and 
Lsm11 are components of the HLB (Liu et al., 2006). I found that Mute colocalised 
with both Lsm10 (Figure 5.11A-C, arrow in C) and Lsm11 (Figure 5.11 E-G, arrow in 
G) in the somatic muscles (Figure 5.11 A-C and E-G) as well as other cells of the 
embryo (data not shown). Co-localisation of Mute with these markers was also 
apparent in salivary gland nuclei (Figure 5.11 D and H, arrows). Coilin is a 
component of the Cajal Body. I found that the Mute positive foci sometimes lay in 
close proximity to but never colocalised with the brighter Coilin positive foci and 
often associated with weaker Coilin positive foci (data not shown). Such associations 
of the HLB and CB have been described previously where low levels of coilin have 
been found in the HLB (Liu et al., 2009). In addition, the localization of Lsm10 and 
Lsm11 was unaffected in the somatic muscles of mute1281/Df embryos (Figure 5.11 I 
and J, arrows). 




Figure 5.11 Mute expression colocalises with histone locus body markers 
(A-C and E-G) Stage 16 WT embryos. Somatic muscles in one hemisegment labeled 
with anti-MHC (pink), anti-Mute-LS (A, E, green), anti-dLsm10 (B, red), anti-
dLsm11 (F, red) and Hoechst (blue). Mute colocalises with dLsm10 (C, arrow and 
inset) and dLsm11 (G, arrow and inset) in somatic muscle nuclei. (D, H) Salivary 
gland nuclei from third instar larvae labeled with anti-Mute-LS (D,H, green), dLsm10 
(D, red), dLSm11 (H, red) and Hoechst (blue). Mute colocalises with dLSm10 and 
dLsm11 in the salivary gland nuclei and associates with the polytene chromosome 
(arrow in D, H). Anti-Lamin labels the nuclear membrane (red outline). (I,J) Stage 16 
mute1281/Df embryos labeled with anti-MHC (red), dLsm10 (I, green) dLsm11 (J, 
green) and Hoechst (blue). dLsm10 and dLsm11 are correctly localized in mute1281/Df 
somatic muscles (I,J, arrows). (K) Hela cells labeled with anti-FLASH (red) and anti-
Mute-LS (green). Mute foci colocalise with FLASH foci (arrows). Scale bar = 10um. 
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Thus, Mute may be a novel component of the Drosophila HLB that is not 
required for the localization of Lsm10 and Lsm11. This might suggest that mute is not 
required for the organization of the HLB. Interestingly anti-Mute-LS also recognized 
a sub nuclear body in Hela cells which colocalied with FLASH (FLICE associated 
huge protein) (Figure 5.11 K). FLASH positive nuclear bodies have been suggested to 
be similar to the Drosophila HLB and has been associated with histone transcription 
(Barcaroli et al., 2006; Bongiorno-Borbone et al., 2008). These results suggest that the 
epitope recognized by anti-Mute-LS might be conserved in vertebrates and that a 
structural/functional homologue of Mute might exist in higher organisms. The 
conservation may lie at C terminus since anti-Mute-LS is raised against the C 
terminus of Mute. 
5.2.7 mute regulates histone mRNA transcription and processing: 
It has previously been shown that mutations in components of the HLB 
prevent normal histone pre-mRNA processing (Godfrey et al., 2006; Godfrey et al., 
2009; Sullivan et al., 2001). This results in the production of aberrantly long mRNAs 
with polyadenylated tails due to the presence of cryptic polyadenylation signals 
downstream of the cleavage site in the histone gene (Godfrey et al., 2006; Godfrey et 
al., 2009; Lanzotti et al., 2002). Since Mute localizes to the HLB, I asked if it was 
involved in the processing of histone pre-mRNA transcripts. To address this I 
performed quantitative RT-PCR (qPCR) on WT and mute1281/Df embryos. I found a 
significant increase in the level of poly-A histone H3 and histone H4 mRNAs in 
mute1281/Df embryos at early stage 17 (Figure 5.12). There was a 7.14 ± 2.9 fold 
increase in misprocessed histone H3 transcripts and a 7.41 ± 1.77 fold increase in 
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misprocessed histone H4 transcripts compared to stage matched WT embryos (Figure 
5.12A). Since U720 and slbp15 mutants have previously been shown to accumulate 
high levels of mis processed histone H3 transcripts (Godfrey et al., 2006; Sullivan et 
al., 2001), I also examined the relative changes in histone transcripts in mute1281 
versus U720 and slbp15. The levels of misprocessed histone H3 and H4 transcripts 
were approximately 5 fold less than that observed in stage 17 slbp15/15 embryos and 
U720/20 mutant third instar larvae compared to stage matched WT controls (Figure 
5.12A). Interestingly Northern analysis showed an increase in levels of normal H3 
and H4 transcripts in mute1281/Df embryos unlike slbp15/15 and U720/20 mutants which 
showed high levels of mostly mis processed transcripts (Figure 5.12D), as has been 
reported previously (Godfrey et al., 2006; Sullivan et al., 2001). Similary, qPCR using 
histone specific primers for the reverse transcription reaction, also showed a 
significant increase in total levels of H3 and H4 trasncripts in mute1281/Df embryos. 
Compare Figure 5.12A-poly A fraction to Figure 5.12C-total transcript. 
An increase in the levels of mis processed histone transcripts might change the 
levels of histone proteins. To test this, histones were extracted from early stage 17 
whole embryos and their levels were analysed on a western blot. Surprisingly, I was 
unable to detect any differences in the overall levels of Histones H3 and H4 (Figure 
5.12B).  The modification of histone tails has been shown to have a major effect on 
higher order chromatin structure by affecting the stability and packaging of chromatin 
and also the transcriptional status of genes. Defects in establishing and maintaining 
the stability of heterochromatin has deleterious effects often leading to disease 
(Delcuve et al., 2009; Zhang and Adams, 2007). During muscle differentiation there is 
large scale reorganization of heterochromatin (Agarwal et al., 2007). Hence I checked 
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the levels of modified Histones H3 and H4. I found that di and trimethyl-H3-(Lys)9 
(di/tri-met H3K9) levels were unaffected in mute1281 (Figure 5.12B). Levels of acetyl-
H3-(Lys)9 (Ac H3K9) was slightly reduced in mute1281/Df embryos but I was unable to 
detect any muscle specific differences by immunofluorescence and was unable to test 
for differences in free pools of histones versus those that were bound to chromatin 
(Figure 5.12B, arrow and data not shown). The Histone variant H2Av has been shown 
to regulate the formation of heterochromatin and also to function in the silencing of 
euchromatic genes (Swaminathan et al., 2005). I found no change in the levels of 
H2Av (Figure 5.12).  
In order to test if there were other detectable changes in the heterochromatin 
of myonuclei, I studied the localization of the non histone protein, heterochromatin 
protein 1 (HP1). HP-1 functions as a gene repressor and localizes to heterochromatic 
regions via interaction with methylated H3K9 but has also more recently been shown 
to localize to transcriptionally active regions as well (Ayyanathan et al., 2003). I 
found that in WT muscles HP1 appeared to surround the heterochromatin and was 
present as a ring (Figure 5.12E-H, arrows and inset in F). Interestingly this circular 
localization was reduced to a punctate form in many of the thin muscles in mute1281/Df 
embryos (Figure 5.12I-L, arrows and inset in J). Some muscles continued to show the 
presence of the circular HP1 stain but the area encircled appeared to be much smaller 
compared to WT (Figure 5.12F and J, arrowhead). The overall levels of HP1 are 
unaffected in mute1281/Df embryos (Figure 5.12B).  
 Chapter 5 Results: Muscle wasted  
 121 
 
Figure 5.12 Histone mRNAs are mis regulated and HP1 localisation is aberrant 
in mute1281 
Quantitative RT-PCR using oligo-dT on total RNA extracted from early stage 17 
embryos. Histone H3 and H4 transcripts are misprocessed in mute1281/Df. A 7.14 ± 2.9 
fold change of poly-A H3 transcripts and 7.41 ± 1.77 fold change of poly-A H4 
transcripts over WT is observed in mute1281/Df (students t-test P < 0.05). Levels of mis 
processed transcripts in slbp15/15 and U720/20 mutants are ~5 fold higher compared to 
mute1281/Df. All values are normalized against the ribosomal gene rp49. (B) Western 
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blot of acid extracted histones and heterochromatin protein 1 (HP1) from 200 WT and 
mute1281/Df early stage 17 embryos. 5ug of protein was loaded per lane. Levels of 
Histone H3, H4, di-met H3K9, tri-met H3K9, H2aV and HP1 are comparable in WT 
and mute1281/Df . The levels of Ac H3K9 are decreased (arrow). (C) qPCR using 
histone specific primers on on total RNA extracted from early stage 17 embryos. 
Histone H3 and H4 transcripts are upregulated by ~14 fold in mute1281/Df. (E-L) Dorsal 
muscles (outlined in F, J) of late stage 16 embryos labeled with Hoechst (blue), anti-
HP1 (red) and anti-MHC (green). HP1 encircles the heterochromatin in WT muscles 
(F, arrow and inset). The localization of HP1 is more punctated than circular in 
mute1281/Df myonuclei (J, arrow and inset). In some cases the area encircled by HP1 is 
smaller (compare F and J, arrowhead). Scale bar = 20um. 
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 Thus, mute appears to regulate histone gene expression possibly by 
functioning as a transcriptional repressor and a pre-mRNA processing factor. The 
presence of mis-processed histone mRNA or increased amounts of normal histone 
trancripts in mute1281 does not affect the overall levels of histone proteins. The 
localization of HP1 is affected in mute1281 which suggests that mute may play a role in 
the organization of heterochromatin. It is possible that by some as yet unknown 
mechanism the presence of mis processed histone transcripts, or some other function 
of mute results in chromatin instability in terminally differentiated muscle cells.  
 
5.2.8 Muscle transcripts are misregulated in mute1281 embryos: 
The loss in muscle mass and change in HP1 localisation observed in mute1281 
might be concurrent with the mis regulation of muscle specific genes. In order to test 
this, quantitative RT-PCRs were performed on early stage 17 WT and mute1281/Df 
embryos. Muscle specific genes that are expressed late in embryonic development 
were chosen for the analysis. Dmef2 is a key regulator of muscle gene expression and 
has been suggested to have multiple functions throughout myogenesis (Sandmann et 
al., 2006). I found that the levels of Dmef2 were slightly but significantly 
downregulated by 0.79 ± 0.08 fold in mute1281/Df compared to WT (Figure 5.13 A, 
Students t-test P<0.05).  The mis regulation of Dmef2 transcripts could in turn cause 
the mis regulation of its target genes. Different genes have been shown to respond 
differently to Dmef2 ((Elgar et al., 2008)). I quantified the levels of some Dmef2 
targets and found that the levels of myosin alkali light chain l (mlc1), myosin alkali 
light chain 2 (mlc2), muscle LIM protein at 60A (mlp60A) and mhc were significantly 
reduced (Figure 5.13 A, P<0.1). Concurrently I also observed a reduction in the levels 
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of MHC protein as shown by a western blot on embryonic extracts at early stage 17. 
This reduction could be attributed to the reduced muscle mass (Figure 5.13 B, arrow, 
quantified in Figure 5.13 C). There was no significant change in the transcript levels 
of Actin57B (act57B) (Figure 5.13 A). CG6972, which is also a proposed Dmef2 
target was significantly upregulated ~3 fold compared to WT (Figure 5.13 A, P<0.1). 
CG6972, an uncharacterised gene, has been proposed to be positively regulated by 
Dmef2 and is expressed specifically in the somatic muscles (Elgar et al., 2008; 
Sandmann et al., 2006) but has also been shown to be upregulated in response to 
hypertrophy induced muscular degeneration (Montana and Littleton, 2006). It is 
possible that the increase observed in mute1281 is due to the muscle wasting defect.   
I also tested the expression levels of the RNA binding protein How (24B) that 
is expressed in both somatic muscles and tendon cells and is required during late 
myogenesis when myotubes begin to attach to their epidermal attachment sites 
(Baehrecke, 1997). I observed a significant reduction in the transcript levels of how in 
mute1281/Df compared to WT (Figure 5.13 A, 0.79 ± 0.05 fold, P<0.05). The how locus 
encodes two isoforms, the long how(L) which is expressed throughout embryonic 
development and the short how(S) which is expressed only at later stages of 
embryogenesis (Nabel-Rosen et al., 1999). I further tested the protein levels of How. 
The levels of How(L) were comparable to that observed in WT but the levels of 
How(S) were significantly reduced in mute1281/Df embryos (Figure 5.13 B arrowhead, 
quantified in C). How has been shown to regulate muscle activity as well as tendon 
cell differentiation. It is known that the levels of How(S) are upregulated in the 
tendon cells during terminal differentiation. It is possible that in mute1281, How(S) 
expressed in both muscles and tendon cells is affected. 
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Figure 5.13 Muscle specific genes are mis regulated in mute1281 
(A) Quantitative RT-PCR on total RNA extracted from early stage 17 WT and 
mute1281 embryos. Fold change over WT is indicated. Levels are normalized against 
the ribosomal protein rp49. SE is shown in red. The horizontal dashed line at 1 
indicates WT level. Dmef2, How, MHC, Mlp60A, Mlc1 and Mlc2 are downregulated 
(P<0.05 for Dmef2, and How. For the rest P<0.1). CG6972 is upregulated (P<0.05) 
Reduction in the levels of Act57B are not statistically significant (P = 0.2). Levels of 
CG11658 (possible fly homologue of Atrogin) is upregulated (P = 0.17) (B) Western 
blot for muscle proteins using extracts from 200 early stage 17 WT and mute1281/Df 
embryos. 10ug of protein was loaded per well. The level of How (L) is unchanged but 
How(S) (arrowhead) and MHC (arrow) are reduced in mute1281. (C) Quantification of 
western blot in B. Levels are normalized against Tubulin. 
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Interestingly I also found an increase in the level of the predicted fly 
homologue of vertebrate atrogin-1, an F-box protein and proposed ubiquitination 
enzyme. cDNA microarrays have previously shown that atrogin-1 levels are 
upregulated specifically in skeletal muscles when they undergo atrophy (Gomes et al., 
2001). The proposed homologue, CG11658 is 26% identical to mouse Atrogin-1 
which in turn is 96% identical to human Atrogin-1 (Gomes et al., 2001). Here I show 
that the levels of CG11658 are dramatically increased by ~30% (P = 0.17) using 
whole embryo extracts (Figure 5.13 A). I was unable to test this specifically in the 
somatic muscles.  
These results show that the expression of muscle specific genes both at the 
transcript and protein levels are significantly affected in mute1281. It is possible that 
the misregulation of all these genes might be due to changes in chromatin 
organization.  Clearly many more muscle specific genes might be affected in addition 
to those tested. 
5.2.9 Other HLB mutants also display defective muscles: 
Mutations in other components of the HLB have been shown to affect the cell 
cycle and oogenesis in Drosophila (Godfrey et al., 2006; Godfrey et al., 2009; 
Sullivan et al., 2001). Thus far none of them have been tested for muscle morphology. 
Hence I asked if any of the other known HLB mutants also show muscle defects. I 
analysed the somatic muscles of slbp15 mutant embryos at late stage 16 and 
lsm11c02047 mutant third instar larvae. Homozygous slbp15 embryos do not display any 
defects in their musculature (Figure 5.14A), but interestingly, in the absence of one 
copy of mute, (mute1281/+, slbp15/15) over half these genotypes (n = 9/15) displayed 
somatic muscles that appeared significantly thinner as compared to WT (compare 
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Figure 5.14A and B, dorsal muscles outlined). Some muscles were detached (Figure 
5.14B, arrow) while others appeared to be missing (Fig. 9B asterisk), similar to the 
mute1281/Df phenotype. Thus mute appears to genetically interact, with slbp to affect 
the somatic muscles. 
lsm11c02047 mutants survive until third larval instar. There was no observable 
defect in the somatic muscles of lsm11c02047 homozygous mutant embryos. Hence I 
analysed their somatic muscles at the third instar larval stage while the larvae were 
still alive. 66.66% (n = 4/6) of the lsm11c02047 homozygous mutant larvae showed a 
loss in muscle striations as compared to the regularly spaced striations in WT larval 
muscles (Figure 5.14C and D). It should be noted that the number of muscles affected 
and the extent of the area affected within a muscle were highly variable. 
Thus, components of the HLB appear to regulate the terminal differentiation 
and integrity of myotubes to various extents. The observed lethality in these mutants 
might be due to defects in tissues that have not yet been analysed. 
 Chapter 5 Results: Muscle wasted  
 128 
 
Figure 5.14 Other HLB mutants display muscle defects 
(A, B) Stage 16 embryos labeled with anti-MHC (red). Homozygous slbp15 embryos 
do not display any muscle defects at this stage (A) but additional removal of one copy 
of mute leads to a muscle defect in 9/15 (mute1281/+;slbp15/slbp15) embryos observed. 
Some muscles are thinner than normal (outlined) while others are detached (arrow). 
Gaps between subsets are wide and muscles appear to be missing (asterisk). (C, D) 
Third instar larvae labeled with anti-MHC (red). WT larvae show the presence of 
regularly spaced striations (C) but lsm11c02047 homozygous mutant larvae display 
fused striations in 4/6 larvae observed (D). The extent of this loss is highly variable. 
Number of muscles and regions within a particular muscle that are affected varies 
greatly. Scale bar = 20um. Vertical bars indicate segment boundaries. Anterior is left, 
dorsal is up.. 
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5.3 Discussion: 
Through a genetic screen for regulators of muscle development I have 
identified mute, whose function appears to be required for the maintenance of muscle 
mass and integrity. I have attempted to characterize in detail, the muscle phenotype 
observed when the mute locus is disrupted. While early myogenic events are 
unaffected, late events of terminal differentiation are compromised. The low levels of 
Kettin and Titin observed at the attachment sites are indicative of defects in either the 
muscle or in both muscle and the specialized epithelial attachment cell, the tendon 
cell. It is known that terminal differentiation of muscles include communication 
between cells of the mesoderm and the overlying ectoderm as muscle growth cones 
seek out their proper attachment sites (Bate, 1992). Extensive studies have suggested 
that reciprocal signaling between the extending muscle and epidermal attachment sites 
leads to the terminal differentiation of the tendon cell and successful myotube 
attachment (Becker et al., 1997). Vein secreted by the muscles activates the EGF 
signaling pathway, upregulating the levels of How(S) in the tendon cells (Nabel-
Rosen et al., 1999). I have shown that the levels of How(S) are significantly reduced 
in mute1281. It is possible that How is affected in both the muscle and tendon cell or 
the degenerating muscles do not secrete sufficient levels of Vein. These issues would 
require further investigation.  
A possible maternal contribution of mute might mask early myogenic 
developmental defects. I was unable to address this since the removal of mute from 
the germ line leads to an absence of egg laying. It is likely that mute too functions in 
aspects of oogenesis similar to what has been shown for other components of the 
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histone pre-mRNA processing machinery, SLBP and U7 (Godfrey et al., 2006; 
Lanzotti et al., 2002; Sullivan et al., 2001). 
It is interesting but not surprising that apoptosis does not appear to be the 
cause of myotube degeneration in mute. While it has been shown that myotubes in 
mib mutants undergo apoptosis (Nguyen et al., 2007), it is also known that a mutation 
in myospheroid (Digan et al., 1986), that causes muscles to round up and detach, is 
not due to apoptosis (Nguyen et al., 2007). The mechanism of muscle degeneration in 
mute is unknown. It has been suggested that the gross loss of muscle mass during 
vertebrate skeletal muscle atrophy is largely mediated by the ubiquitin-proteasome 
system or autophagy/lysosome pathway (Schwartz, 2008). Atrogin-1, a ubiquitin 
ligase has been shown to be upregulated in several models of skeletal muscle atrophy 
(Glass, 2003; Gomes et al., 2001). CG11658 has been proposed by sequence 
homology to be the Drosophila Atrogin-1 homologue (Gomes et al., 2001). It is 
interesting that CG11658 transcripts are upregulated in mute and it is thus tempting to 
speculate that the ubiquitin proteasome pathway might be activated in the atrophying 
muscles of mute.  
I have shown that Mute colocalises with Lsm10 and Lsm11 two components  
of the Drosophila HLB but does not appear to be required for their localization. Mute 
appears to function in the processing of histone pre-mRNAs though the late 
embryonic lethality and muscle degeneration may not be due to the presence of 
aberrant histone transcripts alone.  lsm10, lsm11 and U7 mutants show identical 
timing in the onset of histone pre-mRNA misprocessing although the lsm10 and lsm11 
mutants die as non pharate pupae while U7 mutants are viable though sterile. Also 
slbp15 mutants show an ~ 5 fold increase in the levels of mis processed histone 
 Chapter 5 Results: Muscle wasted  
 131 
transcripts yet do not display any visible muscle defects.  Curiously I also find an 
overall increase in normal histone transcripts in mute mutants, an observation that has 
not been reported for the other characterised processing mutants like slbp, U7, lsm10 
and lsm11. Mute might function in a manner similar to the abnormal oocyte (abo) 
gene product which localises to the histone gene cluster and is a negative regulator of 
histone gene expression (Berloco et al., 2001). These could lead to tissue specific 
changes in histone protein levels, which are difficult to detect. Given the proximity of 
the HLB to the histone gene cluster it is possible that transcriptional and post 
transcriptional activities are closely associated amd yjay yje HLB serves as an 
integrated machinery for histone gene expression. These and possibly other 
undiscovered functions of mute could be responsible for the observed embryonic 
lethality and muscle defects.  
Although Mute does not exhibit any obvious homology to known mRNA 
processing factors, it is predicted to have PAH repeats and weaker predictions are 
suggestive of the presence of a SANT-DNA binding domain and an Atrophin-1 like 
region. All these regions have been implicated in the association with and the function 
of chromatin remodeling complexes (Boyer et al., 2002; Boyer et al., 2004; Heinzel et 
al., 1997; Nagy et al., 1997) although I have shown that the predicted SANT-DNA 
binding domain is not required for maintenance of muscle integrity.  The modification 
of histone tails has been implicated in muscle differentiation (McKinsey et al., 2002; 
Yahi et al., 2006) and deacetylation of histones has been implicated in gene silencing 
(Park et al., 1999). The defects observed in mute1281 are during the late stages of 
development when most cells including myoblasts have exited the cell cycle. 
Although I do observe a small reduction in the levels of Ac H3K9, this may be 
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insufficient to explain the drastic muscle defects observed in mute1281.  Muscles form 
a unique tissue in that they are formed by the fusion of differentiated myoblasts and 
nuclear re-programming occurs as cells fuse to give rise to the mature multinucleated 
muscle. Studies have shown that the differentiation and fusion of C2C12 myocytes is 
accompanied by the remarkable reorganization of constitutive heterochromatin 
domains (Shen et al., 2003; Terranova et al., 2005).  Non histone proteins like HP1 
also function in cell differentiation by associating with heterochromatin.  HP1 
associates with a variety of transcriptional repressors thereby providing a mechanism 
for widespread silencing of gene expression in response to histone methylation 
(Lechner et al., 2000; McKinsey et al., 2000). Although I was unable to detect any 
changes in meH3K9 levels, I have shown that the presentation of HP1 is aberrant in 
the thinner muscles of mute1281. Most studies have largely focused on its role in the 
organization of heterochromatin, but more recently HP1 has been implicated in the 
active transcription of euchromatic genes involved in cell cycle progression (De Lucia 
et al., 2005). Interestingly it has also been shown that the association of HP1 gamma 
increases as vertebrate myoblasts differentiate to form myotubes possibly to stabilize 
transcriptional respression during differentiation (Agarwal et al., 2007).   
The assembly of chromatin into higher order structures plays a critical role in 
the control of gene expression during differentiation. Dmef2, a key regulator of 
myogenesis,  is required for the expression of numerous genes. I have shown that 
Dmef2 transcripts are significantly downregulated. This is likely to have serious 
consequences on the terminal differentiation of muscles. I have also shown that some 
genes that lie downstream of Dmef2 are misregulated in mute1281. It is possible that 
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changes in the levels of these transcripts could have cumulative negative effects on 
terminal differentiation.  
To my knowledge, this is the first report implicating a histone pre-mRNA 
processing factor in the maintenance of muscle integrity.  Perhaps the identification of 
mute can provide some insight into the role of the HLB in differentiated tissue. It may 
well be that mute has functions besides histone pre-mRNA processing that might also 
contribute to the severe muscle degeneration. Interestingly I also find a Mute positive 
nuclear body in Hela cells that colocalises with FLASH suggestive of evolutionary 
conservation. Mutations in survival motor neuron (smn), a CB marker, and a factor 
implicated in snRNP biogenesis (Fischer et al., 1997; Liu et al., 1997), leads to spinal 
muscular atrophy in humans. smn has also been shown in Drosophila to be required in 
both muscle and motor neurons (Chan et al., 2003; Chang et al., 2008). It may well be 
that factors involved in the assembly of processing factors or directly in mRNA 
processing might have functions in tissues like the muscle that involve extensive 
chromatin reorganization due to cell fusion. 
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6 General discussion 
 In Drosophila, myogenesis is tightly controlled, leading to the generation of 
multinucleated muscle fibres at precise locations in the developing muscle pattern. 
Many years of research in the field has uncovered genes that are essential for various 
aspects of muscle development. This work has focussed on some requirements of 






Figure 6.1 Summary  
This schematic presents a summary of work discussed in this thesis.  
 
terminal muscle differentiation. This thesis has explored the role of the intracellular 
domain of a previously characterised gene, Duf, and other downstream factors, in 
regulating fusion efficiency and the possible function of a novel gene, mute, in 
regulating muscle integrity. 
Of the genes involved in myoblast fusion, most are common to both FC and 
FCMs while some are unique to one cell type. These and other undiscovered factors 
may be responsible for the asymmetry in the fusion process. Reiterative myoblast 
fusion leads to drastic changes in cell morphology since membranes are merged and 
reorganised to progressively give rise to larger multinucleated cells with characteristic 
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cytoskeletal elements, the main effectors of cell shape changes. Duf (and Rst) appears 
to be central to this process. The initial recognition between Duf and Sns is likely to 
trigger a cascade of downstream events. I have presented evidence that the 
intracellular domain of Duf is not required for the first round of fusion. Putative 
signaling motifs appear to function additively for subsequent rounds of fusion. There 
appears to be conservation in the intracellular domain requirements of Sns and Duf 
for efficient fusion. Also I have shown that the intracellular domain of Duf interacts 
with both Rols and Loner, two factors linked to elements of the cytoskeleton. It is 
interesting that the initial round of fusion does not require this interaction, although it 
should be noted that under these conditions, fusion is highly inefficient. The 
interaction of Duf with factors that possibly link it to the cytoskeleton, ensures that 
fusion is more robust. This indirectly points to the importance of cytoskeletal 
reorganisation for successful cell-cell fusion and the requirement of relaying 
extracellular signals to the intracellular cytoskeleton. More direct evidence for the role 
of the cytoskeleton lies in the fusion defects observed when actin associated proteins 
like wip, WASp/wave are mutated. 
Interestingly the discovery of kirrel, the zebrafish homologue of duf suggests 
that Kirrel too has similar functions. Kirrel morphants show a significant lack of fast 
muscle precursor formation. Large clusters of unfused myocytes are observed 
(Srinivas et al., 2007). It would be interesting to examine whether mammalian 
myoblasts use aspects of the kirrel pathway for fusion into myotubes.  
In Drosophila, the two main fusion mutant phenotypes observed, namely, no 
fusion and a block at the bi/tri nucleate precursor stage together with subcellular 
changes observed at the precursor stage, led to the two step model that proposed a 
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molecular difference between the initial and subsequent rounds of fusion with the 
precursor lying at the transit point. I have presented evidence that Rols and Loner, 
thought to function only in the subsequent rounds of fusion, also play an essential role 
in the initial round. This initial function requires both Rols and Loner, as shown by 
the rols,loner double mutant. Thus, these two critical factors that have been well 
characterised to lie downstream of Duf, have an earlier redundant function that is Duf 
independent and a later function, that is Duf dependent. Similarly, I have shown that 
other molecules previously characterised to block subsequent (post precursor) steps of 
fusion, are also required earlier on, in combination with rols and loner, for maximal 
fusion efficiency. In addition, I presented evidence that fusion in mutant backgrounds 
can occur quite late in development, past the normal WT fusion time window of mid 
stage 15. Myoblasts in mutants like mbc, fuse at late stages of embryogenesis (late 
stage15-early stage 16), though fusion is minimal. This data supports a recent model 
put forth by Beckett and Baylies (Beckett and Baylies, 2007),  that fusion follows an 
early infrequent phase followed by a late frequent phase and that there may not be 
molecular differences between the initial and subsequent rounds of fusion. It is 
possible that perturbation of the fusion machinery, in the form of these mutants, puts 
pressure on the system and a few fusion events occur later than normal, in an effort to 
try and get past the fusion block. 
Myoblasts are differentiated cells that have exited the cell cycle. With each 
round of fusion, FCM nuclei downregulate FCM specific genes and upregulate FC 
identity genes and muscle structural/differentiation genes. It is understandable that 
cell cycle exit, fusion associated nuclear reprogramming and terminal differentiation 
would involve changes in chromatin organisation and the increased accessibility or 
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inaccessibility of gene promoters to regulatory factors, including chromatin modifying 
complexes. In addition, as transcripts are synthesised they undergo processing like 
capping, cleavage and the addition of a polyA tail, events that are essential for 
translation. Also, previous studies have shown that muscle specific transcripts are 
alternately spliced resulting in the presence of differential transcripts, as muscles 
differentiate (Saitoh et al., 1990).  
In the later half of this thesis, I presented the isolation and characterisation of a 
novel muscle mutant, muscle wasted (mute) that affects terminal muscle 
differentiation leading to a severe loss in muscle mass and integrity. Mute is required 
for histone pre-mRNA processing and appears to be a component of the Drosophila 
histone locus body (HLB). The presence of a similar Mute positive focus in Hela cells 
is suggestive of evolutionary conservation. The HLB contains factors devoted to the 
processing of histone mRNAs (Liu et al., 2006). Although Mute is a ubiquitous 
protein, the sensitivity of the musculature to this mutation possibly arises from the 
complex genetic requirements of muscle differentiation.  
This mutation does not lead to muscle apoptosis although it is tempting to 
speculate a role for the ubiquitin proteasome system. In vertebrate models of muscular 
atrophy, the ubiquitin proteasome system is one of two mechanisms by which gross 
muscle mass is lost. Atrogin-1, a ubiquitin ligase is significantly upregulated in 
models of muscular atrophy. Loss of function atrogin mutants show a reduction in 
muscle atrophy (Bodine et al., 2001; Gomes et al., 2001). It is interesting and curious 
that a mutation in mute leads to an increase in the putative Drosophila atrogin-1 
homologue. Also, genes involved in terminal muscle differentiation like Dmef2 and 
some of its targets, are downregulated in mute. These downregulated genes include 
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mhc, mlc1, mlc2 and mlp84B that are known to play crucial roles in late muscle 
differentiation and are components of the sarcomere. Interestingly, mutations in 
components of the sarcomere lead to severe skeletal and cardiac myopathies in 
humans (Clark et al., 2002; Seidman and Seidman, 2001). Drosophila mlp84 mutants 
die during pupation due to severe sarcomeric defects and a loss of muscle structural 
integrity (Clark et al., 2007). I also showed that How (S) required for tendon cell 
differentiation is downregulated, which might explain the muscle detachments 
observed. These changes in gene expression may be brought about by changes in 
heterochromatisation of the genome. 
I proposed that the increase in mis processed histone transcripts may not be 
entirely responsible for the severe muscle degeneration since other HLB mutants like 
slbp and U7 showed an even greater increase in such transcripts, yet did not display 
any muscle defects and was viable to adulthood, respectively. Yet mute appeared to 
genetically interact with slbp and the lsm11 mutant displayed a loss in muscle 
striations. Surprisingly there was no detectable change in the levels of histone 
proteins. It is possible that excess histone proteins, if produced, are rapidly degraded, 
or measuring overall (chromatin bound and unbound) histone protein levels may not 
be reflective of changes in chromatin associated histones.  
It is possible that mute functions in aspects of RNA metabolism besides 
histone pre-mRNA processing. Recent evidence from an assay in S2 cells, suggests 
that Lsm11 might function in alternate splicing (Park et al., 2004). The 
characterisation of mute perhaps opens avenues for the analysis of mRNA processing 
factors in muscle development. In this regard, a highly conserved, ubiquitously 
expressed mRNA processing factor, Survival Motor Neuron (SMN) has been well 
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associated with spinal muscular atrophy (SMA), a devastating neurodegenerative 
disorder due to the loss of motor neurons, which in turn leads to severe muscle 
atrophy (Schwartz, 2008). Microarray analysis has shown a downregulation of 
sarcomeric genes in SMA patients (Millino et al., 2009). Elegant studies have shown 
that SMN is required for the assembly of snRNPs and is localised to the Cajal body. It 
has also been implicated in splicing (Fischer et al., 1997; Meister et al., 2001; 
Pellizzoni et al., 1998).  
In summary, I have attempted to study two diverse aspects of myogenesis. 
This work throws some light on the downstream functions of Duf, a key player in 
myoblast fusion. It also reveals new roles of Rols and Loner. These results put forth 
clear evidence, for the first time, in favour of a fusion model that is not molecularly 
distinct in the initial versus subsequent rounds of fusion. This thesis is also the first 
report, to my knowledge, of the role of an HLB component in muscle differentiation. 
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